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INTRODUCTION 
  Before entering the study let us know the basic concepts like origin 
of earth, origin of life in it, origin of medicine in mankind. Knowing these 
basics concepts reveals us some truths which glorify our great siddhars 
that they are the pioneers to all modern scientist invariable to the 
department they belong, and also invariable to the country they 
belong.For many scientific evolutions even for todays nano concepts our 
siddhar thoughts are the basics tools for the modern scientist which help  
them in their researches. 
  The age of earth still is a made of great debate. Some used Bible to 
calculate that the earth was created in 4004BC. Later on in the middle of 
the nineteenth century, the great scientist, Charles Darwin believed that 
the earth must be extremely old because he rcognised that natural, 
selection and evolution required vast amounts of time. it was well 
explained by our beloved siddhars which is quoted in our text THOTRA 
KIRAMA ARAICHI. 
  The history of earth describes the most important events and 
fundamental stages in the development of the planet. Nearly all the 
branches of Natural science contribute in understanding the Earth’s 
history. Biological and geological changes have been constantly 
occurring on our planet since the time of its formation. Organisms 
continuously evolve, taking on new forms or going extinct in response to 
an ever changing planet. This is quoted by our siddhars as “ khw;wj;jhy; 
MaJ cyfk;”. Life on earth starts as small and microscopic and then 
into complex multicellular life’s and experienced a rapid diversification 
into the most major phyla and then into chimpanzees to modern humans it 
was quoted as  
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Gy;yhfp g; G+lha;g; G*tha; kukhfpg; 
gy;tpUf khfpg; gwitaha;g; ghk;ghfpf; 
fy;yha; kdpjuha;g; Ngaha;f; fzq;fsha; 
ty;yRuuhfp Kdptuha;j; Njtuha;r; 
nry;th m epd;w ,j;jgtu rq;fkj;Js; 
vy;yug; gpwg;Gk; gpwe;jpisj;Njd; 
     (jpUthrfk;- rpt Guhzk;-26-31) 
 
  As soon as the humans originated in the earth many dramatic 
changes occurred in the aspects of knowledge of the living things. 
Sympathy, caring and love all these contribute more to show the 
difference between the mankind and their primitives. These feelings 
particularly sympathy on others pay the way for the origin of medicines. 
Thus sympathy is the basic step to treatment.  
  Crystallization of knowledge of early humans about plants and 
minerals helps to invent medicines. As soon as the man moves against the 
nature the word “disease” invades the mankind. According to who the 
definition of health is “health is a state of complete physical, mental and 
social well being” . So any system of medicine which fulfills this 
definition of health is said to be the best system of medicine. In this way 
our siddha systems is found to the best system of medicine as it heals the 
man in all aspects by its many wings like internal medicine, external 
medicine, varma, yoga. noi illa neri(social and preventive measures by 
holistic way). 
  ekJ rpj;jh;fs; rpj;j kUj;Jt ghly;fis jkpo; 
nkhopapNyNa vOjp cs;sdh;. vt;thW ekJ jkpo;nkhop kw;w 
nkhopfSf;F Kjd;ik nkhopahf cs;sNjh mJNghyNt ekJ 
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rpj;j kUj;JtKk; kw;w kUj;Jtq;fSf;F Kjd;ik kUj;Jtkhf 
,Uf;f Ntz;Lk; vd;gjw;F ,JNt jf;f rhd;W. 
  ekJ rpj;j kUj;Jtk; gQ;rG+jj;jpd; mbg;gilapNyNa 
mike;J cs;sJ. gQ;rG+jj;jpd; Nrh;f;ifahy; Ritfs; 
cz;lhfpwJ. (Ritfs; ghl;L)  
kz;ZlNd Gdy;jPf;fhy; 
 Liwahfr; Nrh;e;jpl;lhy; tUNk ,dpg;G 
jpz;zkpyk; Jth;g;gpurk; 
 rjhfjpNah lhh;jPapd; jplkh Kiwg;Gk; 
vz;zhpa frg;GKz;lhe; 
 jz;zPhpy; fdypizg;gh nyOkh Kth;g;G 
cz;zhpa mWRitapd; 
 gpwg;gpnjDk; FUrpj;j Uiuj;j kiwNa 
- kUj;Jtj; jdpg; ghly;fs; 
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gQ;rG+jk; 
                                         
Ritfs; 
 
mtw;wpd; khWghL 
 
Fw;wq;fspd; khWghL 
 
Neha;fs; 
 
vf;Fw;wk; Nflile;jJ vd;W FwpFzk;  
ehbahy; mwpjy; 
 
rkdgLj;Jk; Rit cs;s kUe;Jfs; 
 
 
Neha; ePq;fy; 
  Psoriasis is an unrelieved provocative non contagious skin and 
joint disease that affects our immune system. The white blood cells (T-
cells) become over-stimulated and it commonly causes red crusty dry 
patches (also called psoriatic plaques or lesions) to emerge on the skin 
because of the excessive skin production. The skin reacts just the same 
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with the fungus infection. Researchers believe that inheritance, 
atmosphere, and the immune system may also play a primary role in 
psoriasis. 
  If you have psoriasis it will affects your immune system results an 
abnormally hasty skin cell cycle and usually itchy and feel sore. The 
process of having psoriasis begins at the bottom layer of the epidermis, 
where keratinocytes are completed. Keratinocytes are juvenile skin cells 
that fabricate keratin, a strong protein that helps the structure of hair, nails 
and skin. 
  Generally, skin cells that are produced in the deepest layers of our 
skin make their way to the outside in just a week or less. They are full-
grown, that sloughed off the skin, and replaced with novel skin cells from 
underneath. Our skin cannot get rid of these cells as much as necessary 
speed, so they fabricate up and doing, leading to chunky, dry patches, or 
plaques, silvery, crumbling areas of dead skin. 
 
  They usually rise in your elbows, feet, palms, legs, face wrists, 
lower back and knees but can also affect any area such as our scalp and 
genitals but overall it can also affects our whole body. In relation with 
eczema, psoriasis is more prone to be found on the peripheral portion of 
the joint (psoriatic arthritis). Our fingernails and toenails can also affect 
with psoriasis (psoriatic nail dystrophy or nail lesions). 
  Psoriasis is not curable skin disease from time to time improving 
and worsening especially if you were triggered to scratch them. Some 
people with psoriasis can rise in the colder winter months while others in 
the warmer months in increased sunlight exposure. Patients with psoriasis 
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can explode by changes in climate, stress, infections, a drug-related rash 
and dry skin and excess in alcohol. 
  Psoriasis can infected worldwide, whatever your gender and race, 
either you are baby, teen or an adult but most of the patients can only 
diagnosed in their early adult years. People with rigorous psoriasis may 
have collective awkwardness, job strain, expressive anguish and other 
delicate issues for the reason that the outward show of their skin. 
  About 25-40% of patients with psoriasis can also develop psoriatic 
arthritis and still cannot be diagnosed especially if the symptoms are 
placid. They usually develops between the early 30’s to the late 40’s; on 
the other hand, as mentioned on the previous paragraph that it can affect 
of any age of any gender worldwide and 5.7 to 7.5 millions of people in 
the United States or 2 to 2.6 percent of the total population suffers 
psoriasis. 
  There are different types of psoriasis but regardless of what type 
you have it usually causes you a discomfort life. And because of 
psoriasis, most patients can be awake even at night because of the itchy 
feeling. The pain can be difficult to handle and some even think to finish 
their life because of discomfort. 
  Being a patient with psoriasis will be suffers a lifelong treatment 
and therapy and can losing all your financial investment just for the 
medications. so for this reason the author  had selected a efficient 
compound herbal drug which is also very cost effective to the patients. 
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AIM AND OBJECTIVES 
Aim: 
 The aim of this dissertation is to bring out the effectiveness of a 
compound herbal drug against autoimmune diseases like kalanjaga 
padai.(Psoriasis) without the side effects from siddha system of medicine. 
OBJECTIVES: 
Primary objectives: 
 To evaluate the clinical efficacy of Neeradi muthu vallathy melugu 
as internal medicine and kalappai kizhangu velipoochu as external 
medicine For the diseases kalanjaga padai ( Psoriasis) 
Secondary objectives: 
- To study the efficacy of additional therapies like yoga and 
azanas  
In heeling the disease along with the internal and external 
medicine. 
- To discuss the various literary evidence in both siddha and 
modern text books for the disease kalanjaga padai. 
- To confirm the diagnosis in siddha system with the help of 
modern parameters 
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- To know the extent of correlation of features given under 
kalanjaga padai with the features of psoriasis. And there by 
enlightening the highness of siddha system. 
- To know the chemical and bio chemical analysis of the selected 
drug. 
- To study the Pharmacological analysis of the selected drug. 
- To have an idea of an incidence of kalanjaga padai with 
reference of age, sex, socio- economic status, and family history 
related to any psychosomatic problems, land where they 
(Nilam) live and (Paruva Kalam) climatic changes. 
- To make an awareness among the patients in order to avoid 
further recurrence of the disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 9 
REVIEW OF LITERATURE 
A. SIDDHA ASPECTS 
fhshQ;rfg; gil; ;; ;; ;  
 
NtW ngaHfs;:;;;  
 ‘nrk;nghl;L Njhyow;rp> nrjpy; cjpHTg; gil> rhk;gy; gil    
         Ez;zpa njhw;W nrjpy;gil ” 
- mUq;fiyr; nrhy; mfu Kjyp; ; ;; ; ;; ; ;  
 ‘ntz;gUr; nrjpy;> nrjpy; cjpH Neha;” 
- rpj;j kUj;Jtk; rpwg;G; ; ; ;; ; ; ;; ; ; ;  
Definition 
According to the textbook “Siddha Maruthuvam Sirappu” 
Kalanjaga padai is a chronic non - infectious, recurrent, inflammatory 
disorder of the skin characterized by reddish, slightly elevated patches 
covered with silvery white scales 
In Siddha system, skin disorders are brought under the clinical 
entity “Kuttam”. 
In the text book “Aathma Ratchamirthamennum Vaiththiya 
Saarasangiragam” the characteristics of Kuttam are mentioned as follows: 
White scaly patches will appear in Foot, Hand, Lips, Vertex, 
Finger and Wrists. 
T.V. Sambasivam Pillai has mentioned that in Tamil medicine 
‘Kuttam’ means cutaneous affections and so it’s a comprehensive term 
used for various skin diseases. 
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In this book, ‘Sorikuttam’ has been compared to Psoriasis 
(Sorikuttam - A Kind of leprosy with diffuse papillary eruptions without 
ulceration on the entire surface of the body marked by intense itching and 
burning sensation followed by exfoliation of the epidermis or brawny 
scales – eczematous psoriasis, lepra icthyosis) 
Classifications 
 In the Siddha literature “Yugi Muni Vaidhya Chinthamani” the 
kuttam has been classified into 18 types: 
 
‘Kj;jhFk; Fl;le;jhNd gjpndl;Lf;Fk; 
Kdpahd A+fp ehd; nrhy;yf; Nfsha; 
gj;jhFk; Gz;lhpff; Fl;lj;NjhL 
nghUfpd;w tpw;Nghlf Fl;lkhFk; 
gj;jhFk; ghkf;Fl;lk;> frrh;kFl;lk; 
ghpthd fh;zFl;lk;> rpFuFl;lk; 
fpj;jhFk; fpUl;bzf;Fl;lk;> mTJk;guf;Fl;lk; 
nfbahd kz;lyFl;lK khnkd;Nd 
Fl;lkhk; ];ghpr Fl;lnkhL 
Fbykhk; tprh;r;rpff; Fl;lkhk; 
tl;lkhk; tpghjp Fl;lNkhL 
kUtyh fPBg Fl;l rh;kjy 
jpl;lkhe; Njj;jpU Fl;lNkhL 
rpj;Jkh Fl;lk; rjhU Fl;lk; 
Jl;lkhU Fl;le; jd;Ndhnlhf;f 
Rak;ghd gjpndl;L Fl;lkhr;Nr” 
 
1. Gz;lhPfk ;  - Padar Thamarai 
2. tpw;Nghlfk ;  - Koppula perunoi 
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3. ghkk;   - Sirangu perunoi 
4. f[rh;kk ;  - Yaanai thol perunoi 
5. fuzk;   - Kaadhu perunoi 
6. rpFuk ;   - Tholperunoi 
7. fpUl;bzk ;  - Karuperunoi 
8. mTJk;guk ;  – Athikkai perunoi 
9. kz;lyk ;  - Valaya perunoi 
10. mghprk;   - Vali perunoi 
11. tprh;r;rpfk ;  - Sori perunoi 
12. tpghjpfk;  - Senkuttam 
13. rh;kjyk;   - Tholvedippu perunoi 
14. fpBgk;   - Pandrithol perunoi 
15. jj;JU    - Thadippu perunoi 
16. rpj;Jkh    - Naa perunoi 
17. rjhU    - Purai perunoi 
18. RNtjk;   - Venkuttam 
Among the eighteen types of skin diseases (kuttam) described by 
Yugi, clinical features of Virpodaga kuttam, Sadharu kuttam and Thethru 
kuttam resemble those of Kalanjaga padai.  
   jd;te;jphp itj;jpaNuhfk; -18 tif 
1. fghyk; 
2. rhh;Nkfk; 
3. cJk;guk; 
4. fpBgk; 
5. myrk; 
6. rjhPfk; 
7. tprh;r;rpfk; 
8. kz;lyk; 
9. mFNeha; 
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10. tpthjpfk; 
11. Njj;JU 
12. Gz;lhpfk; 
13. tpw;Nghlfk; 
14. rh;kjyk; 
15. ghkk; 
16. ffhee;jp 
17. ntz; 
18. rpj;Jkh 
 
Classification by Anubava Vaithiya Deva Ragasiyam; 
Based on Three thodams 18 types of kuttram has been classified as 
follows: 
Vatham    Kabala Kuttam 
Pitham    Avuthumbara Kuttam 
Kabam    Mandala Kuttam 
     Visharchiga Kuttam 
Vatha Pitham   Rusiya Jimmiga Kuttam 
Pitha Kabam   Saruma Kuttam 
     Yega Kuttam 
     Kidiba Kuttam 
     Sithma Kuttam 
     Alasa Kuttam 
Kaba Vatham   Vibathiga Kuttam 
Thirithodam    Thaththuru Kuttam 
     Pundareega Kuttam 
     Satharu Kuttam 
     Virpodaga Kuttam 
     Bama Kuttam 
     Sarmathala Kuttam 
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     Kakasa Kuttam 
In his dictionary T. V. Sambasivam Pillai has mentioned that, 
according to Tamil Medical Science kuttam is of 18 types; 
1. ePh;   - Leprosy with serous exudation 
2. ntz;   - White Leprosy 
3. nrhwp   - Psoriasis 
4. fUq;   - Black Leprosy 
5. ngUk;  - True Leprosy 
6. nrq;   - Macular Leprosy 
7. nghwp   - Leprosy with Granules 
8. thp   - Leprosy with Fissures 
9. vhp   - Leprosy with burning sensation 
10. tpuy;Fiw  - Lepra mutilans 
11. ril   - Leprosy with confluent ulcers 
12. ahid  - Thick skinned Leprosy 
13. jpkph;   - Anaesthetic Leprosy 
14. tpuz   - Ulcerated Leprosy 
15. fha;   - Nodular Leprosy 
16. Rop   - A form with sloughing ulcers 
17. fpUkp   - Leprosy with microbes 
18. Mwh   - Incurable Leprosy 
 
Mj;kul;rhkph;jk; itj;jpa rhurq;fhuk; -4 tif 
 
1. ntz;Fl;lk; 
2. nrq;Fl;lk; 
3. fUq;Fl;lk; 
4. ngUtpahjp 
 
jpU %yh;;;; - 18 tif 
         fpue;jp Nkfj;jhy; tUgit  - 6 
  tz;bdhy;     - 8 
         GOthy;     - 4 
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Aetiology 
In “Yugi Muni Vaidhya Chinthamani” and “Thirumoolar 
Vaithiyam” we can find out the sources of information on aetiology and 
clinical features of the above disorders. In “Thirumoolar Vaithiyam”, the 
aetiology is given as follows; 
“tpahjpAs; %thW tpsq;fpa Fl;lq;Nfs; 
Rahjpf; fpue;jp Roy; Nkfj;jh yhWk; 
gahjp kz;Zsg; gy tz;bdh nyl;Lk; 
epahjp GOehyha; epd;wjpf; Fl;lNk” 
- jpU%yh;;;; 
• Six types of skin diseases are caused by venereal disease 
“fpue;jp Rod; Nkfj;jhyhWk;” 
• Eight types of skin diseases are caused by insect bites 
“gahjp kz;Zsg; gy tz;bdh nyl;Lk;” 
• Four types are caused by worms infestation. 
   “epahjp GOehyha; epd;wjpf; Fl;lNk” 
 
Guru Naadi Nool describes Aetiology as follows 
„fpUkpahy; te;j Njhlk; ngUfTz;L 
Nfl;fp yjd; gphpTjid fpukkhfg; 
nghUkp tUk; thAnty;yhk; fpUkpahNy 
GOf;fb Nghy; fhZkJ fpUkpahNy 
nrUkp tUk; gTj;jpuq;fs; fpUkpahNy 
Njfkjpy; nrhhpf;Fl;lk; fpUkpahNy 
JUkp tUQ; RNuhzpjq; fpUkpahNy 
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#l;rKld; fphpirg;ghy; njhopy; nra;tPNu’     - FUehb 
The text book “Siddha Maruthuvam Sirappu” describes the 
aetiological factors of “Kalanjaga padai” as follows: 
 Unknown Aetiology  
 Genetic Cause 
 “Agathiyar mentioned that Kanmam (genetic predisposition) is the 
main cause for kuttam in his Kanma Kandam as follows: 
‘Nrh;e;j Fl;lnkhL FiwNehafs; te;j 
NrjpNfs; kyuhj tUk;g nfha;jy; 
jhhpe;j rPh; nre;J tijfs; nra;jy; 
jha; je;ij kdJ nehe;J Nuhfe;jhNd”    
‘jhndd;w nja;tTUj; jidaopj;jy; 
rhh;thd nghpNahh;fs; jikg; gopj;jy; 
fhndd;w ee;jtdk; G+Q;nrbfs; ntl;ly; 
fUkklh rhPuj;jpw; fhR NghNy 
A+ndd;w Tlk;ngy;yhk; nkhl;L nkhl;lh 
Ald; ntSj;J FiwNahAjpuQ; rpe;Jk; 
thndd;w fUkq;fs; jPh;g;gjw;F 
tiunahd;W nrhy;Ntd; Nfs; ee;jtd;ikNa” 
o Plucking the unflowered buds 
o Cruelty to animals 
o Destroying statues of god 
o Teasing of elderly people 
o Destroying forests and gardens. 
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  The text “Agathiyar paripoornam - 400” describes the Psycho-
social causes (Kanma Varalaru) 
“gotpidahy; tp\g;G+r;rp fbj;j Njh\k; 
            ghjfh;f;F xU ehSk; jPh;tjpy;iy 
  cstpidah Yhlhgpf; nfhs;s te;j 
            cz;ikaJ mwpahky; %h;f;fQ; nra;thh; 
  fstpidAe; jPh;tjpy;iy fbdnkj;j 
            fUizAs;s G+uzj;jpy; fz;fhl;rp 
  mltpid eP fhZKd;Nd mfyr; nrhy;yp 
           milahsk; tpuy; FWF kpd;dq;NfNs” 
- nra;As; 214; ;; ;; ;  
tpuy; FWFq;fhy jpkpUk; tp\k; NghNyWk; 
nka;aOe;Je; jiy RoYk; ntSf;F Nkdp 
gukhd Njfnky;yhe; jbj;J tPq;Fk; 
ghjnky;yhk; ntbj;J kpf;F Gz;Z fhZk; 
rurKld; nrhhp fug;ghd; gzk; Nghy; NjhZk; 
rhe;ijahNk tpe;ijnfLj; jbj;J tPq;Fk; 
ghUyfp ype;Neha;f;F kUjPahNj 
ey;Nyhiug; gopj;j Fl;lq;fd;dkhNk 
- nra;As; 215; ;; ;; ;  
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In Agathiar Paripooranam 400 it has been mentioned that diseases 
which are caused due to sins committed in the previous birth will be 
cured only if kanmam is expiated. 
 
‘Mr;nrd;w gjpndl;L Fl;le;jhDk; 
mtuth;fs; nra;fpd;w mjh;kj;jhyhk; 
njr;nrd;w rpthyaj;jpYr; rpl;lq;fs; 
nra;jth;fs; rpt epe;ij gz;zpdhh;fs; 
%r;nrd;w nghpNahiu Jbj;Njhh;fs; 
%h;f;fkha; milf;fyj;ij vLf;fpd;whh;fs;  
Mr;nrd;w jpizastpd; Fiwe;j $yp 
nfhLf;fpd;Nwhh; Fl;lj;jpw; $LthNdh” 
                               - A+fpKdp-800 
  Excessive heat and cold, laziness, excessive sleep in day time, 
unbridled sexual       indulgence, robbery etc..These  habits are supposed 
to be the factors which lower the immune mechanism of the body 
(Iyarkkai vanmai) and makes the body liable to disease. 
  Excessive intake of food items which are hard to digest, 
imbalanced food, vomiting, frequent intake of food mixed with stone and 
hair. 
            Prolonged mental depression, intention to spoil others, greed, 
abusing God and noble people, neglecting orphans and beggars, cursing 
the elders and so on. These were the causes mentioned by Yugi. 
In Agstiar Kanmakandam,  
                   ‘Nrh;e;j Fl;lnkhL FiwNeha;fs; te;j 
    NrjpNfs; kyuhj mUk;G nfha;jy; 
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jhhpj;j rpt nre;J tijfs; nra;jy; 
jha; je;ij kdJ nehe;J Nuhfe;jhNd”     
- mfj;jpah; fd;kfhz;lk; 
 
• Plucking buds 
• Domestic violence 
• Hurting the parents 
 
In Dhanvandhri Vaithiyarogam he Mentions 
‘mwptpd;wp tghPj Nruhfhuk; Grpf;fyhYk; 
Jiwapd;wp njhlhj njhd;iw njhl;litg; Grpf;fhYk; 
Fiwnfhz;l eprpj;jkhd Fykq;if aLr;rhYk; 
epiwnfhz;l nghpNahh; jk;ik epe;jpj;Jg; NgryhYk; 
epe;jpj;Jg; Gwj;jpahw; Nrhk epiy nflg; gphpf;fyhYk; 
te;jpj;Jg; G+Uth nrd;khe;jpu ghtj;jhYQ; 
re;jpf;ff; fw;Gkhjh; jq;fisf; fUjyhYk; 
njhe;jpj;j Fl;lNuhfe; njhLf;F nkd;Wiuj;jhh; Kd;Ndhh;” 
                                              
- jd;te;jphp itj;jpaNuhfk; 
 
• Intake of allergic foods 
• Intake of contaminated food 
• Thinking of females 
• Destiny (Kanma vinai) 
• Scolding the elders 
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In Manmurukiyam, he Mentions, 
                     ‘,lk; nghO JdT njhopNyhL gUtk; 
vdkpit NtWgLj yhYk; 
  eQ;#wy; eQ;R $baJ nghWk; 
gpzpAw yhWk; epwk; ngah;jLNk” 
                                                                
-khd; kWf;fpak; 
• Change of place, food, work, climate and diurnal 
Toxins by animal bites 
In Agasthiyar vaithyam he mentions, 
‘Fay;tha; F\;lk; raq;Fd;kk; ePhpopT Ruf;fpuhzp 
   ePuilg;G ghz;L %y tha;T 
fay; thA tUq;fz;zpy; Fj;jha; fbe; jrthA 
fzthf Kd; nra;j caph; tpidjhNd” 
                                                         
- mfj;jpah; itj;jpak; 
 Skin diseases 
 Tuberculosis 
 Diabetes 
 Fever 
 Diarrhea 
  These diseases occurs due to destiny 
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Triggering Factors of Kalanjaga Padai are: 
a) Tonsilitis (Lasuna thabitham) 
b) Respiratory disorders (Puppusa pinigal) 
c) Allergic disorders (Ovvamai) 
d) Stress and strain  
e) Anxiety, Depression 
f) Seasonal variations. 
g) Certain drugs (eg.) Thambira chendhooram, Chloroquin, Polio 
Vaccine 
Clinical Features 
In the text book “Siddha Maruthuvam Sirappu” written by Dr. 
R. Thiagarajan the clinical features of “Kalanjaga padai” have been 
given as follows: 
 Erythematous slightly elevated patches of different sizes and 
shapes (commonly coin shaped) covered with white silvery 
scales appear all over the body. It may also occur in scalp and 
face 
 Pinpoint bleeding appears on scratching the lesions 
 In children the lesions may be like water drops 
In chronic cases; 
 Thickening of skin with fissures appears in both palms and 
soles 
 Excessive scaling and generalized erythema develops all over 
the body 
 Mild oozing will be present if flexures (axilla groin) are 
involved in females 
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 In one fourth of the patients, nails are affected (pitting, 
transverse ridges will be seen) 
 In 7% of the patients, joints are affected (Psoriatic arthropathy) 
 
PSORIATIC ARTHROPATHY (Kalanjaga Vatham;): 
Kalanjaga padai is often associated with painful joints known as 
“Kalanjaga vatham”.It may affect any joint. The most often affected 
joints are inter-phalangeal joints. The terminal interphalangeal joints are 
usually involved as opposed to the proximal interphalangeal joints in 
“Uthira vatha suronitham” which is identical with rheumatoid arthritis. 
In these cases the affected fingers show nail changes. This condition is 
termed as “Psoriatic Arthropathica” 
The joints of fingers, ankles, knee and sacroiliac region are 
selectively affected. Those joints are swollen and painful with psoriatic 
lesions. Radiological changes are characteristic and consist of 
osteoporosis followed by increased density, diminished joint space, 
erosion of joint surfaces followed by eventual destruction of the ends of 
bones. Ultimately, the joints become deformed.  
Yugi muni describes the clinical features of Kalanjaga vatham as follows; 
“thjkhq; fhy; ifapy; Fuq;fpuz;Lk; 
tUj;J re;J KWf;fpNa File;J nehe;J 
ehjkh eil jhDe;jhd; nfhlhky; 
eype;JNk Klkhfpf; fuL fl;br; 
NrjkhQ; rle;jhD kpf ntSj;Jj; 
jpdNthL rpuq;Fkha;r; Nrl;gkhfpf; 
fhjkh aUrpnahL kaf;fkhFk; 
fUjpa fhshQ;rfkhk; thjkhNk”      - nra;As; 259; ;; ;; ;  
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‘thjkhq; fhy; ifapy; Fuq;fpuz;Lk; 
  tUj;J re;J KWf;fpNa File;J nehe;J” 
The joints of fingers, feet, ankles, knee and sacroiliac are 
selectively affected and these joints are painful. 
‘ehjkh eil jhDe;jhd; nfhlhky; 
eype;JNk Klkhfpf; fuL fl;br;” 
The deforming erosive arthritis targets fingers and toes. Marked 
cartilage destruction and bony articulation results in loss of joint space 
and marked instability.  
“Nrjkhe; rle;jhD kpf ntSj;Jj; 
jpdNthL rpuq;Fkha;r; Nrl;gkhfpf; 
fhjkh aUrp nahL kaf;fkhFk; 
fUjpNa fhshQ;rfkhk; thjkhNk” 
The whole body becomes pale (anaemic). Well-defined 
erythematous papules which are sharply demarcated appear on the skin. 
There is also loss of taste and giddiness. 
 
Neha; fzpg;G tpthjk;; ; ;; ; ;; ; ; 
Among the eighteen types of skin diseases (kuttam) described by 
Yugi, clinical features of Virpodaga kuttam, Sadharu kuttam and Thethru 
kuttam resemble those of Kalanjaga padai.  
The clinical features of Virpodaga kuttam are as follows: 
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tpw;Nghlff;; ;; ;; ; Fl;lk;:; ;; ;; ;  
“GJikaha;r; rhPunkq;Fe; jpdTz;lhFk; 
nghUntbaha;j; jpf;nfdj;jPf; nfhOe;J Nghy 
nkJikaha; tpl;nlhpAk; ey;y ghk;gpd; 
tp\g;glk; NghNy jbj;J ntSg;G khFk; 
RJikaha; kpfr; nrhhpAQ; rptg;GkhFk; 
Jhf;fnkhL rQ;ryKk; kpfTz;lhFk; 
fJikaha; Njhnyy;yhe; jbg;Gz;lhFk; 
fdj;jtpw; Nghlfkhd Fl;le;jhNd” 
     - A+fp Kdp ngUEhy; 800;;;  
Characterized by elevated skin lesions with erythema and itching. 
Burning sensation will be present on and off. Usually these entities are 
associated with anxiety and despair. 
rjhU Fl;lk;; ;; ;; ;: 
         “vj;jhd nthpg;NghL jpdTkhFk; 
vspjhd Nrl;Lkthjj; Jw;gj;jp 
gj;jhd fl;bg; Gz;ZkhFk; 
ghk;G Njhy; Nghw;wpiue;J gUj;Jf; fhZk; 
tpj;jhd %f;NfhL fhJ fd;dk; 
kpfj;Jbg;ghQ; rjhU F\;le;jhNd” 
     - A+fp Kdp ngUEhy; 800;;;  
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Characterized by skin lesions covered with silvery white scales, 
erythema, itching, burning sensation and thickening of ears, cheeks and 
nose 
Njj;JU;;;  Fl;lk;; ;; ;; ;: 
“rh;ke;jhd; rptg;ghf tl;lzpj;Jr; 
ryit Nghy; ntSf;FNk jpdTz;lhFk; 
th;ke;jhd; NuhfkJ kpfTz;lhFk; 
kapnuy;yhQ; RUz;LNk cz;ilahFk; 
fh;ke;jhd; gpj;j Nrl;Lk kpFf;Fk; 
fhae;jhd; fjpj;JNk jpkpUz;lhFk; 
jh;ke;jhd; rlnky;yh %jyhFk; 
jhf;fhd Njj;jpUf; F\;le;jhNd” 
                       - A+fp Kdp itj;jpa rpe;jhkzp 800; ;; ;; ;  
Annular erythematous lesions with whitish appearance, itching, 
oedema of the body and rolling of hairs like balls are the characteristic 
clinical features in this entity. 
 
Mukkuttram Verupadugal: 
a. Vatham: 
In case of kalajaga padai 
1. Abanan  - habitual Constipation 
2. Viyanan  - erythematous changes in the affected areas of 
skin 
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3. Samanan  - due to other vayus, it is affected 
4. kirukaran - loss of appetite 
5. Devathathan - insomnia like condition 
are commonly affected 
b. Pitham: 
In case of kalanjaga padai 
1. Anal pitham  - indigestion of food 
2. Ranjagam  - paleness of the conjunctiva and tongue 
3. Sathagam  - difficulty to do the routine works  
        properly and  sluggishness 
4. Pirasagam  - dryness and roughness of skin  
   are commonly affected 
c. Kabam:  
 In case of kalanjaga padai, 
1. Kilethagam  - loss of appetite 
2. Tharpagam  - burning sensation of eyes may be  
  present 
3. Santhigam  - joint pain present in very few cases   
  are commonly affected 
 Udal Kattugal 
Our body consists of seven udal kattugal. It gives strength and 
structure to our body.In the case of Kalanjaga padai out of seven udal 
kattukkal saaram, senneer, oon and enbu are commonly affected. 
Saaram  : Dryness, roughness, tiredness 
Senneer  : Erythematous patches present 
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Oon   : Impairment of sense organ. 
Kozhupu  : Synovial Fluid Secretion affected 
Enbu             : joint pain present in few cases         
     
UDAL VANMAI (Body Immunity) 
The Udal Vanmai is classified into 3 types. They are, 
 lyarkai Vanmai 
 Seyarkai Vanmai 
 Kaala Vanmai 
 
IYARKAI VAN MAI 
Natural immunity of the body itself by birth. 
SEYARKAI VANMAI 
Improving the health by intake of nutritious food materials, 
activities and medicines. 
KAALA VANMAI 
Development   of   immunity   according   to   age   and   the  
environment. 
When Udalvanmai is affected there may be a possibility of 
Kalanjaha Padai. 
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PINIYARI MURAIMAI 
(Diagnostic methods adopted in Siddha system of Medicine) 
Piniyari muraimai is a method of diagnosing a disease. It is based 
upon three main principles. They are, 
 Poriyalarithal (Inspection) 
 Pulanalarithal (Palpation) 
 Vinathal (Interrogation) 
Physicians 'pori' and 'pulan' are used as tools for examine the 'pori 
pulan' of the patient. The above principles correspond to the 
methodology of  
1. Inspection,  
2. Interrogation  
3. Palpation in modern medicine, in arriving a clinical diagnosis of 
the  disease. 
1. PORIYALARITHAL 
Pori is considered as the five senses of perception namely, 
 Nose 
 Tongue 
 Eye 
 Skin 
 Ear 
 ‘Poriyalarithal’ is examining the pori of the patient by the 
physician for diagnosing.  
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• Skin is commonly affected in kalanjagapadai. 
• Ear lobes are rarely affected in kalanjagapadai.  
• So skin and ear is used to diagnose the disease  
2. PULANALARITHAL 
'Pulan' is five object of senses. They are 
 Smell 
 Taste 
 Vision 
 Sensation to touch 
 Hearing 
Pulanalarithal' means examining the 'pulan' of the patient by the 
physician for diagnosing purpose.  
♦ Dryness,roughness are elicited by touching  the skin  
3. VINATHAL 
Vinathal is gathering the informations regarding the history of the 
disease, its clinical features etc., from the patient or his immediate 
relatives who are taking of him, when the patient is not in a position to 
speak or the patient is a child.  
♦ Vinathal is use ful to know about the exacerbations based on 
seasonal variations  
ALAVAIGAL (logics) 
  Alavaigal are used in clinical diagnose of a disease 
 
 29 
     ‘fhz;ly; fUjy; ciu mghtk; nghUs; xg;ghnwd;gh; 
msit NkYk; xopGz;ik ikjpfr; Njhbay; ngd ehd; 
fsit fhz;gh; mitapw;wpd; NkYk; miwth; mitnay;yhk; 
msit fhz;ly; fUjy; ciu vd;Dk; %d;wpylq;fpLNk” 
rptrpj;jpahh; msit vz;; ; ;; ; ;; ; ; 6 
 
Alavai divided in to ten types. They are, 
• Observation - fhz;ly;          
• Inference -         fUjy; 
• Authority, Literature -  ciu 
• Preception - mghtk; 
• Presumption - mUj;jhgj;jp 
• Comparison - cgkhdk; 
• Inference by elimination - ghhpNr\k;  
• Probability -         rk;gtk; 
• Tradition - Ijpfk; 
• Natural Inference - ,ay;G 
The above mentioned "ten alavaigal" are included in three 
alavaigal. 
They are, 
• Kaandal (Inspection by Siddha method)] 
  Through 'kaandal' the physician can directly see the patient,  
hear all the complaints and at length concludes a diagnosis. 
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Karuthal (Through Siddha Investigation) 
  Through envagai thervu and neerkuri as well as neikuri, we 
can diagnose a disease by karuthal. 
Urai (Text's evidence - Siddhar's) 
   Comparative study of the signs and symptoms of the patient 
with the reference of books and come to diagnosis. 
 
Ubamanam  
    It is very use ful to differentiate kalanjapadai from other skin 
diseases  
Iyalbu 
  It explains about the features of  kalanjapadai 
 
Ennvagai thervugal (eight diagnostic tools) 
Siddhars have developed a unique method of diagnosing the 
disease by "Enn vagai thervugal' 
                   “ehb ];ghprk; eh epwk; nkhop tpop 
kyk; %j;jpuj;ij kUj;JtuhAjk;” 
- Neha; ehly; Neha; Kjy; ehly; (Kjy; ghfk;) 
 
“nka;f;Fwp epwk; njhdp tpop eh ,Ukyk; iff;Fwp” 
- Njiuah; 
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1. Naadi (Pulse) 
        In kalanjaga padai the following types of naadi could be felt. They 
were, 
a) Vathapitham 
b) Vathakabam 
c) Pithakabam 
II. Sparism  
In case of Kalanjaga padai slightly raised well defined dry 
erythematous macules or plaques, covered with white silvery scales can 
be noticed in affected areas. 
III. Naa 
In case of Kalanjaga padai no abnormality was seen in Naa.  
IV. Niram 
   In case of Kalanjaga padai white patches with silvery scales could 
be noticed at affected areas. 
V. Mozhi 
     In case of kalanjaga padai, no abnormalities were observed. 
VI.Vizhi 
     In case of Kalanjaga padai, no abnormality was seen in vizhi. 
VII.Malam 
In case of Kalanjaga padai constipation was reported in some 
cases. 
VIII.Moothiram 
      Collection of urine for the determination of Neerkkuri and 
Neikkuri, is an important dignostic method 
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NEERKKURI AND NEIKURI 
“mUe;J khwpujKk; mtpNuhjkjha; 
m/fy; myh;jy; mfhyT+d; jtph;e;jow; 
Fw;ws tUe;jp cwq;fp itfiw 
Mbf; fyrj; jhtpNa fhJnga; 
NjhU K$h;j;jf; fiyFl; gLePhpd; 
epwf;Fwp nea;f;Fwp epUkpj;jy; flNd” 
    - rpj;j kUj;Jthq;f; ; ;; ; ;; ; ;  RUf;fk;;; ; 
Prior to the day of urine examination the patient is instructed to 
take a balanced diet. The patient should have good sleep. After waking up 
in the morning, the first urine voided is collected in a clear wide mouthed 
glass container and is subjected to analysis of “Neerkkuri and neikkuri” 
within one and a half hour 
“te;j ePh;f;Fhp iail kzk; Eiu vQ;rnyd; 
          iwe;jpa Ysit aiwFJ KiwNa” 
    - rpj;j kUj;Jthq;f; ; ;; ; ;; ; ;  RUf;fk;; ;; ;; ; 
1. Niram       -    Colour 
2. Edai          -     Specific gravity 
3. Manam     -     Smell 
4. Nurai         -     Frothy nature 
5. Enjal          -     Quantity of urine voided 
Apart from these the frequency of urination, abnormal constituents 
such as sugar, protein, presence of blood, pus, renal crystals must also be 
found out. 
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In Kalanjaga padai patients straw coloured urine was noticed. 
NEIKKURI: 
The speciality of neikuri is stated in in the text book ‘Siddha 
Maruthva Noi Naadal Noi Mudal Nadal Thirattu’  as follows: 
“epwf;Fwpf; Fiuj;j epUkh zePhpw; 
rpwf;f ntz;nza; Nahh; rpWJsp eLtpLj; 
njd;Wwj; jpwe;njhyp Nafhjikj;jjp 
dpd;wjptiy Nghk; newptpopawpaTk; 
nrd;wJ GfYQ; nra;jpia AzNu” 
The collected specimen as said above is to be analysed by 
following method. The specimen is kept open in a glass dish or china clay 
container.It is to be examined under direct sunlight, without any shaking 
of the vessel. 
Then add one drop of gingelly oil through the side of vessel 
without disturbing the urinary specimen and the neikkuri was noted in 
direct sunlight, and conclude the diagnosis as follows:  
“muntd ePz;bd/Nj thjk; 
MopNghw; gutpd; m/Nj gpj;jk; 
Kj;njhj;J epw;fpd; nkhopt njd; fgNk 
Mutpy; MopAk; muTk; 
mutpy; Kj;Jk; Mopapy; Kj;Jk;” 
-rpj;j kUj;Jt Neha; ; ; ;; ; ;; ; ;
ehly; Neha; Kjdhly; ; ; ;; ; ;; ; ;
jpul;L;;;  
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In my Kalanjaha padai dissertation, 
♦ 60 % cases have Vatha Neer 
♦ 10% cases have pitha Neer  
♦ 30 % cases have Kaba Neer. 
 
Medicine like Pranayamam, Yoga. 
 
LINE OF TREATMENT (gpzpePf;fk; P ; ;P ; ;P ; ; - ghpfhuk;);;;  
In accordance with the Siddha system of medicine, certain basic 
principles are developed before starting the specific drug therapy. These 
procedures are initially followed to balance, the deranged kutrams ie. 
Vatham, pitham and kabam.They are purgation, vomiting and application 
of drugs on the eyes to balance the deranged vatham, pitham and kabam 
respectively. This can be understood by the following verbs, 
“tpNurdj;jhy; thjk; jhOk; 
tkdj;jhy; gpj;jk; jhOk; 
mQ;rdj;jhy; Iak; jhOk;” 
In addition to this following medications are practiced in the 
Siddha system. 
 Aga marunthugal (Internal medicines) 
 Pura marunthugal (External medicines) 
 Restriction regarding food habits and routine day to day life 
style. 
 Sirappu    Maruthuvam    -    a    special    feature    of   Siddha 
medicine like Pranayamam,Yoga. 
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 Internal Medicine: 
Neeradimuthu Vallathy Mezhugu 500 - 700mg twice daily 
External Medicine: 
Kalappaikizhangu Velipoochu  
 
Paththiyam (Dietary Regimen): 
SPECIAL NON - DRUG THERAPEUTICS 
Several special medicaments of non-drug therapeutics like Yoga, 
Pranayamam, Asanas, Kalpa medicines are employed in Siddha system. 
These are employed during diseased state and  also for the prevention of 
diseases during healthy days. 
In Kalanjaha padai, patients are also advised to follow 
Pranayamam, Yoga and Asanas for the early cure, in order to avoid the 
remissions and exacerbation of this disease. 
PRANAYAMAM 
It is a form of Kayakalpa method. By practicing this one can 
prevent any disease. This is explained in the following verse, 
nra;Kiw;;; : 
 Rfhrdj;jpypUe;jgb 2 cjLfSk; ntspNa nfhQ;rk; ehf;if 
kbj;Jf; Foy; Nghy; Mf;fpf; nfhz;L ‘,];” vd;w xspAld; 
thahy; fhw;iw ,Of;fNtz;Lk; Kbe;jtiu cs;Ns itj;jpUe;J 
%f;F topNa nky;y tplNtz;Lk;. 
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Neu msT 
 10-30 epkplk; tiu gofyhk; 
Vw;wfhyk;; ;; ;; ; 
 nta;apw;fhyj;jpy; gof Vw;wJ 
gad; : 
1. clypd; ntg;gk; jzpAk; 
2. ,uj;jk; Rj;jp ngWk; 
3. grp ed;F vLf;Fk; 
4. ehl;gl;l Njhy; tpahjp 
5. mrPuzk; 
6. kz;zPuy; Neha; 
7. %yk; ,tw;iw Fzkhf;Fk;  
8. eQ;Rjd;ikia nty;Yk; ty;yik ,jd; %yk; 
ngwg;gLtjhy; ,ijg; goFgth; ghk;G,Njs; fbahy; 
ghjpf;fgLtjpy;iy  
YOGA: 
Yoga is maintained by the body in a particular posture for a 
particular period of   time. This is totally different from the ordinary 
exercise. Yoga vitilises,    both physical body and the mental set-up 
unlike exercise which tones only the muscles. The common benefits are, 
 It tones the internal organs 
 It prevents obesity and disease 
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 It maintains normal circulation to all the organs of the body. 
 It is very safeguard for all the vital organs. 
 It avoids laziness, enhances pure mind and cleverness and 
memory power. There will be no problems like psychomotive 
disturbances if practised daily. 
 
ASANAS 
Regarding skin disease the following Asanas can be adviced 
1. gj;khrdk; 
2. rh;thq;fhrdk; 
3. G+uz rtrhe;jp Mrdk; 
1. gj;khr;;; dk;;;; 
rkjsj;jpy; rk;kzkpl;L cl;fhh;e;J tyg;ghjj;ij ,lj; 
njhilkPJk;> ,lg;ghjj;ij tyJ njhil kPJk; Vw;wp ,uz;L 
iffisAk; Kd; Gwk; xd;wpd; gpd; xd;whf Nfhh;j;J 
kyh;e;jpUf;FkhW ,Uj;jy;> ,jdhy; cly; eyKk; kd kfpo;r;rpAk; 
Vw;gLk;. 
gad;:;;;  
 nrhpkhd rf;jp cz;lhf;Fk;  
  cly; eyKk; kdkfpo;r;rpAk; Vw;gLj;Jk; 
 Kf;Fw;wq;fSk;  jd;dpiygLk;  
 euk;Gfs; tYtilAk;  
 fPy;thA jPUk; 
2. rh;thq;fhrdk; ;; ;; ; ; 
ky;yhe;J gLj;J fhy;fis nkJthf xl;bagbNa NkNy 
J}f;fpg; gpd; Gl;l ghfj;ijAk;> ,Lg;Gg; ghfj;ijAk; NkNy J}f;fpf; 
iffshy; KJFg; Gwj;jpy; jhq;fp epw;wy;. 
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gad;:;;;  
 eiu> jpiu> %g;ig khw;wp ,sik cz;lhf;Fk;  
 clypd;  vy;yh cWg;GfSk; gyg;gLk; 
 tPjd Nfhsq;fs; J}z;lg;gLk; 
 ngUk; Neha; jPUk; 
 fUg;ig NfhshW jPUk;  
 kyr;rpf;fy;  
 ehb gykpd;ik  
 jiytyp  
 mypj;jd;ik 
   
3. G+uz rtrhe;jp Mrdk;; ;; ;; ; 
ky;yhe;J gLj;Jf; fhy;fis NeuhfTk;> iffis clNyhL 
gf;fthl;bYk; itj;J Neuhfg; gLj;J ,Uj;jy;. 
 ,J fisg;igf; Nghf;Fk; 
 Gj;Jzh;r;rpia cz;lhf;Fk; 
 ehb kz;lyq;fs; cWjp ngWk; 
 kNdhrf;jp tsUk; 
 jirfs; jsh;e;J Gj;Jzh;r;rp ngWk; 
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gpuhzahkk; 
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MODERN ASPECTS 
ANATOMY OF THE SKIN 
The skin is an ever-changing organ that contains many specialized 
cells and structures. The skin functions as a protective barrier that 
interfaces with a sometimes-hostile environment.  
It is also very much involved in maintaining the proper temperature 
for the body to function well. It gathers sensory information from the 
environment, and plays an active role in the immune system protecting us 
from disease.  
Understanding how the skin can function in these many ways starts 
with understanding the structure of the 3 layers of skin - the epidermis, 
dermis, and subcutaneous tissue 
EPIDERMIS 
The epidermis is the outer layer of skin. The thickness of the 
epidermis varies in different types of skin. It is the thinnest on the eyelids 
at 0.05 mm and the thickest on the palms and soles at 1.5 mm. 
The epidermis contains 5 layers. From bottom to top the layers are 
named: 
o Stratum Basale 
o Stratum Spinosum 
o Stratum Granulosum 
o Stratum Lucidum 
o Stratum Corneum 
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Stratum Basale 
The stratum basale is the bottom layer of keratinocytes in the 
epidermis and is responsible for constantly renewing epidermal cells. 
This layer contains just one row of undifferentiated columnar stem cells 
that divide very frequently. Half of the cells differentiate and move to the 
next layer to begin the maturation process. The other half stay in the basal 
layer and divide over and over again to replenish the basal layer. 
Stratum Spinosum 
Cells that move into the spinosum layer (also called prickle cell 
layer) change from being columnar to polygonal. In this layer the cells 
start to synthesize keratin. 
Stratum Granulosum 
The cells in the stratum granulosum, or granular layer, have lost 
their nuclei and are characterized by dark clumps of cytoplasmic material. 
There is a lot of activity in this layer as keratin proteins and water-
proofing lipids are being produced and organized. 
Stratum Lucidum 
The stratum lucidum layer is only present in thick skin where it 
helps reduce friction and shear forces between the stratum corneum and 
stratum granulosum. 
Stratum Corneum 
The cells in the stratum corneum layer are known as corneocytes. 
The cells have flattened out and are composed mainly of keratin protein 
which provides strength to the layer but also allows the absorption of 
water. 
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Specialized Epidermal Cells 
 
            There are three types of specialized cells in the epidermis 
 
• The melanocyte produces pigment (melanin) 
• The Langerhans' cell is the frontline defense of the immune 
system in the skin 
• The Merkel's cell's function is not clearly known 
Epidermal Appendages     
The following glands and structures are found in the epidermis: 
Eccrine Glands 
These are the sweat glands. They are found in abundance 
throughout the skin surface, except margins of the lip, labia minora , 
glans penis and inner aspect of the prepuce. These are also found in 
highest concentration in the palm, soles and the axillae. They secrete 
sweat that is a hypotonic solution, which permits evaporative cooling of 
the body. 
Apocrine Glands 
These are the scent glands .They are found primarily in the axillae 
and ano- genital region. Modified apocrine glands are found in the ear 
canal, eyelids and in the breasts.  
Sebaceous Glands 
These are found on all parts of the body except the palms and 
soles. They produce oil that lubricates and protects the skin and hair. This 
oil is called the sebum 
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Hair 
  Hair is found on almost every part of the body surface except on 
the palms, soles and the dorsal surface of the terminal phalanges. Hair 
differs in length, thickness and colour. It grows about 1-2 cm per month. 
The growth of Hair is controlled by endocrine. 
Nails     
These are semi transparent plate like horny structures, covering the 
dorsal surfaces of the distal phalanges of the fingers and toes. The 
proximal edge of the nail is known as the nail root; the visible portion of 
the nail is called the nail plate. It is semi transparent and looks red due to 
the abundant vascular supply in the nail bed. The more opaque and rather 
whitish semi lunar portion of the nail plate near its root is known as the 
lunula. The surface of the skin on which the nail rests is known as the nail 
bed. 
DERMIS 
The dermis varies in thickness depending on the location of the 
skin. It is 0.3 mm on the eyelid and 3.0 mm on the back. The dermis is 
composed of three types of tissues 
o Collagen 
o Elastic tissue 
o Reticular fibers 
Layers of the Dermis 
The two layers of the dermis are the papillary and reticular layers. 
o The upper papillary layer contains a thin arrangement of 
collagen fibers 
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o The lower reticular layer is thicker and made of thick collagen 
fibers that are arranged parallel to the surface of the skin 
Specialized Dermal Cells 
The dermis contains many specialized cells and structures 
• The hair follicles are situated here with the Arrector pili muscles 
that attaches to each follicle 
• Sebaceous (oil) glands and apocrine (scent) glands are associated 
with the follicle. 
• This layer also contains eccrine (sweat) glands, but they are not 
associated with hair follicles 
• Blood vessels and nerves course through this layer. The nerves 
transmit sensations of pain, itch, and temperature 
• There are also specialized nerve cells called Meissner's and Vater-
Pacini corpuscles that transmit the sensations of touch and pressure 
Subcutaneous Tissue 
 
The subcutaneous tissue is a layer of fat and connective tissue that 
houses larger blood vessels and nerves. This layer is important in 
regulation of skin temperature and the body.  
 
PHYSIOLOGY 
1. Protective Function 
It prevents the penetration of harmful substances and bacterial 
invasions and protects against sunlight by synthesis of melanin pigment. 
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2. Immunological Function 
Langerhans cells play a crucial role in the contact sensitization, 
immuno surveillance against viral infections and neoplasms 
3. Sensory Functions 
The skin is richly supplied with nerves and various types of 
specialized sensory end-organs which provide information regarding 
environmental changes. By this, the body can adjust its activities 
accordingly.  
4. Secretion and Excretion 
The skin possesses various types of glands and the most important 
of them are Sweat and Sebaceous glands. These glands secrete Sweat and 
Sebum respectively. The substances excreted in Sweat are Sodium 
Chloride, Sodium Phosphate, Sodium Bicarbonate, Keratin and a small 
amount of Urea. The skin can also excrete certain drugs administered to 
the individual such as Mercury, Arsenic, Iodine etc. 
Sebum is composed of Fatty acids, Cholesterol, Alcohol etc. The 
Sebum acts as a lubricant for the drying effects of atmosphere. 
5. Synthesis of Vitamin D 
Vitamin D is synthesized in the skin as a result of exposure to ultra 
violet ‘B’ (UVB) radiation.  
6. Body heat regulation 
The skin plays a very important role in regulation of heat loss. It 
loses heat to the external environment in three ways by Conduction, 
Radiation and Evaporation. The heat loss through the skin is regulated by 
various physiological mechanisms.  
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7. Endocrine function 
Hair follicles and Sebaceous glands are the targets for androgenic 
steroids secreted by the gonads 
8. Storage function of skin 
Blood is stored in the rich sub papillary plexus of the dermis 
(approximately 1 litre). The skin is also a good store house of ergosterol 
which is irradiated by the Ultra Violet light of the sun and converted into 
Vitamin D 
9. Absorption 
The skin can absorb substances dissolved in fatty solvents. This is 
the principle behind the local application and massaging of various 
ointments and creams dissolved in animal fats. 
10. Gaseous exchange through skin 
A small amount of gaseous exchange occurs through the skin. In 
man, the amount of CO2 exchanged through the skin is negligible when 
compared to the amount exhaled from the lungs 
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PSORIASIS 
General Description: 
             Psoriasis is an immune mediated genetically determined common 
dermatological disorder which affects skin, nails, joints and has various 
systemic associations. There is evidence that the disease is associated 
with a high impact on the health-related quality of life and considerable 
cost. Large literature has been published focusing on its varied aspects. 
There is a no dearth of information available; however, many questions 
remain that are still unanswered.  
  Although the disease can develop at any time, 10-15% of all cases 
are diagnosed in children under 10, and the average age at the onset of 
symptoms is 28. Psoriasis is most common in fair-skinned people and 
extremely rare in dark-skinned individuals. 
  Normal skin cells mature and replace dead skin every 28-30 days. 
Psoriasis causes skin cells to mature in less than a week. Because the 
body can't shed old skin as rapidly as new cells are rising to the surface, 
raised patches of dead skin develop on the arms, back, chest, elbows, 
legs, nails, folds between the buttocks, and scalp. 
  Psoriasis is considered mild if it affects less than 5% of the surface 
of the body; moderate, if 5-30% of the skin is involved, and severe, if the 
disease affects more than 30% of the body surface. 
Definition: 
Psoriasis is non contagions, chronic, autoimmune disease 
commonly characterized by thickened, inflamed patches of skin covered 
by silver-gray scales, sometimes accompanied by painful joint swelling 
and stiffness 
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Etymology: 
 The term psoro comes from the Greek word for 
itch; psoriasis corresponds to the term itchy. The term psoriasis was used 
as early as 1684 as the Latin term for Mange. [Mange is simply another 
word for scabies, a very itchy mite infestation] 
Prevalence 
         There is a growing number of population-based studies providing 
worldwide prevalence estimates of psoriasis. Prevalence of psoriasis 
varies in different parts of the world. According to published reports, 
prevalence in different populations varies from 0% to 11.8%.  For most of 
the data given, the range extends from around 0.5% to close to 2.5%. In 
the USA, the prevalence of psoriasis was estimated to be around 4.6% 
while in Canada it was 4.7%. Data from Europe show little variation in 
countries with a range from 1.4% (Norway), 1.55% (Croatia) and 1.6% 
(UK). In East Africa, the figure was 0.7% and in the Henan district of 
China only 0.7% were found affected. 
 
  Most of the data on prevalence has been derived from hospital-
based studies while there are only few well-defined large population 
based studies done to find the exact prevalence of this dermatoses in the 
community.  
 
  Prevalence studies from India are mostly hospital-based. presents 
the comparative data from various epidemiological studies on psoriasis 
from India. Okhandiar et al. collected a comprehensive data from various 
medical colleges located in Dibrugarh, Calcutta, Patna, Darbhanga, 
Lucknow, New Delhi and Amritsar. They found that the incidence of 
psoriasis among total skin patients ranged between 0.44 and 2.2%, with 
 50 
overall incidence of 1.02%. They noted that the incidence in Amritsar 
(2.2%) was higher as compared to other centers in Eastern India and 
speculated that it may be related to different environmental conditions 
(extremes of temperature), dietary habits, and genetic differences. The 
ratio of male to female (2.46:1) was very high which could not be clearly 
accounted for. Highest incidence was noted in the age group of 20-39 
years and the mean age of onset in males and females was comparable. 
 
  In another study from North India, Bedi  reported the prevalence of 
psoriasis to be 0.8% among the skin patients but the sample size of the 
study was very small. Male to female sex ratio was 2.5:1. In this study, it 
was observed that females had lower mean age of onset compared to 
males. In a latter study by Bedi, which included larger number (530) of 
subjects, prevalence of psoriasis among dermatology outpatients was 
found to be 2.8% while male to female ratio continued to be the same.  
 
  In a study from tertiary health care center from North India, 
psoriasis patients accounted for 2.3% of the total dermatology 
outpatients. Of the total psoriasis patients, 67% were men and 33% were 
women, male to female ratio being 2.03:1. Ages of patients ranged from 
infancy to eighth decade, mean age being 33.6 years. Children accounted 
for 4.4% of total psoriasis patients. Women had slightly lower mean age 
of onset (27.6 years) compared to the men (30.9 years).  
 
  So, it can be inferred that in India the prevalence of psoriasis varies 
from 0.44 to 2.8%, it is twice more common in males compared to 
females, and most of the patients are in their third or fourth decade at the 
time of presentation. These studies are limited by the absence of 
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commonly accepted and validated diagnostic criteria. Furthermore, there 
is basically no reliable information on time trends of the disease. 
 
Table 1 :Epidemiological studies on psoriasis from India 
 
 
Genetic and familial incidence: 
         Psoriasis vulgaris is known to be associated with certain HLA 
antigens and complement factors but most of the studies published are in 
Western populations with only little information about Indians. Chablani 
et al. in a study of 67 psoriasis subjects from Western India found 
association with the A1, B17 and Cw6, but not with B13 antigens. 
Pitchappan et al. reported association of HLA Bw57 and DR7 with 
psoriasis vulgaris in South India. Rani et al.  showed that Cw *0602 was 
the main allele that had high frequency in psoriasis patients in North 
India. 
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Genetic predisposition has a significant role in the etiopathogenesis of 
psoriasis and familial clustering of the cases has been observed. Farber et 
al. reported familial occurrence in 36% of their patients. Familial 
incidence is greater in childhood psoriasis compared to adult onset 
psoriasis.  
 
  Indian studies report lower familial incidence of the disease. Bedi  
reported positive family history of psoriasis in 14% of their patients. 
While Kaur et al. reported family history in only 2% of their patients. 
First degree relatives were affected in 84% of the cases while second 
degree relatives in 12% cases. There are only few studies which have 
made record of family history of psoriasis in their patients, so definite 
statistical data on familial incidence is not available. 
Quality of life 
• 60 percent of people with psoriasis reported their disease to be a 
large problem in their everyday life 
• Nearly 40 percent with psoriatic arthritis reported their disease to 
be a large problem in everyday life 
• Patients with moderate to severe psoriasis experienced a greater 
negative impact on their quality of life 
• Psoriasis has a greater impact on quality of life in women and 
younger patients 
 
CAUSES 
• The cause of psoriasis is not fully understood. There are two main 
hypotheses about the process that occurs in the development of the 
disease. The first considers psoriasis as primarily a disorder of 
excessive growth and reproduction of skin cells. The problem is 
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simply seen as a fault of the epidermis and its keratinocytes. The 
second hypothesis sees the disease as being an immune-mediated 
disorder in which the excessive reproduction of skin cells is 
secondary to factors produced by the immune system 
Psoriasis - an Autoimmune Disorder 
• As part of its defense against foreign invaders, our body's bone 
marrow and thymus gland collaborate to pump out specialized 
white blood cell warriors called "T cells." Under normal 
circumstances, T cells are programmed to identify and coordinate 
an attack on enemy combatants. 
• In psoriasis, T cells mistakenly identify skin cells as "other" and 
attack them. This attack injures the skin cells, setting off a cascade 
of responses in immune system and in skin, resulting in skin 
damage (that is, swelling, reddening and scaling). 
• In an effort to heal, skin cells begin reproducing rapidly. Activities 
that should take a month take place in only days, and abnormally 
large numbers of new skin cells push their way to the surface of 
skin. This occurs so quickly that older skin cells and white blood 
cells aren't shed quickly enough. These discarded cells pile up on 
the surface of the skin, creating thick, red plaques with silvery 
scales on their surface: the hallmark of the classic form of plaque 
psoriasis 
 
Factors that increase the risk of developing psoriasis include: 
• family history 
• stress 
• exposure to cold temperatures 
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• injury, illness, or infection 
• steroids and other medications 
• race 
  Trauma and certain bacteria may trigger psoriatic arthritis in 
patients with psoriasis. 
Clinical Symptoms: 
o A sharply delimited, hyperemic patch, covered with a silvery-white 
layer of scales of variable thickness, is found as typical primary 
eruption 
o With careful scratching, small silvery-white lamellar scales come 
off, more or less as from a solidified candle strip (candle grease 
sign) 
o Phenomenon of the last skin layer: if scratching continued, a thin, 
glistening epithelial layer is revealed 
o Auspitz sign: removal of this epithelial layer reveals punctuate 
bleeding because of a lesion of the capillaries running out into the 
tips of the papillae. 
o Koebner’s phenomenon: if the skin of a psoriatic patient is 
irritated (e.g. scratching) in the phase of an acute episode of 
eruption, a new psoriatic focus is formed on the floor of this 
epithelial lesion 
Types of psoriasis: 
  Dermatologists distinguish different forms of psoriasis according to 
what part of the body is affected, how severe symptoms are, how long 
they last, and the pattern formed by the scales. 
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PLAQUE PSORIASIS. 
  Plaque psoriasis (psoriasis vulgaris), the most common form of the 
disease, is characterized by small, red bumps that enlarge, become 
inflamed, and form scales. The top scales flake off easily and often, but 
those beneath the surface of the skin clump together. Removing these 
scales exposes tender skin, which bleeds and causes the plaques 
(inflamed patches) to grow. 
  Plaque psoriasis can develop on any part of the body, but most 
often occurs on the elbows, knees, scalp, and trunk. 
SCALP PSORIASIS.: 
  At least 50 of every 100 people who have any form of psoriasis 
have scalp psoriasis. This form of the disease is characterized by scale-
capped plaques on the surface of the skull. 
NAIL PSORIASIS:  
  The first sign of nail psoriasis is usually pitting of the fingernails or 
toenails. Size, shape, and depth of the marks vary, and affected nails may 
thicken, yellow, or crumble. The skin around an affected nail is 
sometimes inflamed, and the nail may peel away from the nail bed. 
GUTTATE PSORIASIS.: 
  Named for the Latin word gutta, which means "a drop," guttate 
psoriasis is characterized by small, red, drop-like dots that enlarge rapidly 
and may be somewhat scaly. Often found on the arms, legs, and trunk and 
sometimes in the scalp, guttate psoriasis can clear up without treatment or 
disappear and resurface in the form of plaque psoriasis. 
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PUSTULAR PSORIASIS.  
  Pustular psoriasis usually occurs in adults. It is characterized by 
blister-like lesions filled with non-infectious pus and surrounded by 
reddened skin. Pustular psoriasis, which can be limited to one part of the 
body (localized) or can be widespread, may be the first symptom of 
psoriasis or develop in a patient with chronic plaque psoriasis. 
  Generalized pustular psoriasis is also known as Von Zumbusch 
pustular psoriasis. Widespread, acutely painful patches of inflamed skin 
develop suddenly. Pustules appear within a few hours, then dry and peel 
within two days. 
  Generalized pustular psoriasis can make life-threatening demands 
on the heart and kidneys. 
  Palomar-plantar pustulosis (PPP) generally appears between the 
ages of 20 and 60. PPP causes large pustules to form at the base of the 
thumb or on the sides of the heel. In time, the pustules turn brown and 
peel. The disease usually becomes much less active for a while after 
peeling. 
  Acrodermatitis continua of Hallopeau is a form of PPP 
characterized by painful, often disabling, lesions on the fingertips or the 
tips of the toes. The nails may become deformed, and the disease can 
damage bone in the affected area. 
INVERSE PSORIASIS. 
  Inverse psoriasis occurs in the armpits and groin, under the breasts, 
and in other areas where skin flexes or folds. This disease is characterized 
by smooth, inflamed lesions and can be debilitating. 
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ERYTHRODERMIC PSORIASIS.  
  Characterized by severe scaling, itching, and pain that affects most 
of the body, erythrodermic psoriasis disrupts the body's chemical balance 
and can cause severe illness. This particularly inflammatory form of 
psoriasis can be the first sign of the disease, but often develops in patients 
with a history of plaque psoriasis. 
PSORIATIC ARTHRITIS.  
  About 10% of partients with psoriasis develop a complication 
called psoriatic arthritis. This type of arthritis can be slow to develop and 
mild, or it can develop rapidly. Symptoms of psoriatic arthritis include: 
• Joint discomfort, swelling, stiffness, or throbbing 
• Swelling in the toes and ankles 
• Pain in the digits, lower back, wrists, knees, and ankles 
• Eye inflammation or pink eye (conjunctivitis). 
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PATHOGENESIS 
The biochemical basis for the pathogenesis of psoriasis, which is as 
equally varied as the genetic basis, can be attributed to both 
overexpression and underexpression of certain proteins in psoriatic 
lesions. The anomalies in protein expression can be divided into three 
areas:  
A. Abnormal keratinocyte differentiation 
B. Hyperproliferation of the keratinocyte 
C. Infiltration of inflammatory elements 
 
A. Keratinocyte Differentiation 
At least six markers of abnormal keratinocyte differentiation have 
been found, and all have implications in the pathogenesis of the disease. 
These include aberrations of  
• Keratinocyte Transglutaminase type I (TGase K) 
• Skin-derived Antileukoproteinase (SKALP) 
• Migration inhibitory factor-related protein-8 (MRP-8) 
• Involucrin 
• Filaggrin 
• Keratin expression 
TGase K - The overexpression of this enzyme causes the excessive 
cornification seen in psoriatic lesions. 
SKALP – It is found only in psoriatic skin. This polypeptide is a major 
elastase inhibitor, which is specific for the degredation of elastin, a 
protein found in tissues requiring elasticity.  
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MRP-8 - Its biochemical function is not completely understood. It has 
been found in psoriasis and other inflammatory diseases but not in normal 
skin. 
Involucrin - A precursor protein that helps to stabilize the CE, is also 
upregulated in psoriasis vulgaris. 
Keratin - Its expression is also disrupted in psoriasis. K6 and K16, 
markers of abnormal hyperproliferative conditions, are up-regulated in 
psoriatic epidermis, whereas K1 and K10, markers of terminal 
differentiation, are down-regulated.  
Filaggrin -It is normally found in the granular layer of the skin and is 
absent in psoriaticlesions. 
B. Hyperproliferation 
 It is the second category of anomalies that contributes to the 
symptoms of psoriasis vulgaris. Several possible biochemical causes for 
the overproduction of the keratinocytes have been found in psoriatic skin: 
• Epidermal Growth Factor (EGF) 
• Bone Morphogenetic Protein-6 (BMP-6) 
• Transforming Growth Factor-alpha (TGF-α) 
• Ornithine Decarboxylase 
• Activating Protein (AP1) 
• Mitogen-Activated Protein Kinase (MAPK) 
 EGF binding capacity is doubled in the upper layers of the 
epidermis of psoriatic skin. This increase in binding over-stimulates the 
growth of the keratinoctyes, causing hyperproliferation. 
          BMP-6, another growth factor, is present in newborns, but 
normally disappears by adulthood, except in psoriatic patients, which 
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makes it a prime candidate for a growth factor sponsoring the formation 
of psoriatic lesions in humans. 
          TGF-α expression is up-regulated in psoriatic skin.  
          Ornithine Decarboxylase, an essential enzyme in polyamine 
biosynthesis, is higher in lesional and nonlesional psoriatic skin. 
          AP1, a complex of the oncoproteins, stimulates the expression of 
many genes that are important in cell proliferation and inflammation. 
          The last indicator, MAPK, helps to regulate cellular proliferation. 
Numerous growth factors and cytokines modulate MAPK's activity, 
which is higher in psoriatic fibroblasts.  
          C. Inflammatory Elements 
          The inflammatory aspect of psoriasis is physically evident by the 
redness of psoriatic plaques. The biochemical basis for this inflammation 
stems from several immune modulators including various cytokines 
released from keratinocytes and other proteins involved in the 
inflammatory response. 
Among the interleukins (ILs), IL-1, IL-6, IL-7 and IL-8 are up 
regulated in psoriatic skin. In addition, IL-15, which reduces keratinocyte 
cell apoptosis, is elevated in psoriatic lesions. Pituitary Adenylate 
Cyclase Activating Polypeptide (PACAP) is an inflammatory mediator 
that is up regulated in psoriatic lesions. 
All of these inflammatory factors exert specific effects on T cells, 
endothelial cells, macrophages and neutrophils, which in turn spawn the 
immunogenic inflammatory response seen in psoriasis. 
In the last few decades, however, this view has changed and it is 
now well accepted that psoriasis is in fact an immunologically mediated 
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disease where activation of T lymphocytes is central to the inflammation 
in the dermal microenvironment and the epidermal hyper proliferation is 
secondary to the inflammatory events that follow a Th1 type of immune 
response. 
T Cells 
In psoriasis, the activity of T cells is the driving force for induction 
and maintenance of the skin lesions. 
T Cell Activation 
Activation of T cells requires three steps 
• Binding 
• Antigen specific activation, known as signal 1 
• Non-antigen specific cell-cell interaction, known as signal 2 
Binding 
The T cell attaches to the Antigen Presenting Cell [APC] through 
surface adhesion molecules. In skin the Langerhans cell is the most 
efficient Antigen Presenting Cell. 
Antigen specific activation 
Once the T cell-APC binding has occurred through their respective 
surface adhesion molecules, the antigen is presented to the T cell by the 
APC. This antigen stimulated activation leads to conversion of the naïve 
T cell into an antigen specific cell that may further develop into a long 
lived memory cell that circulates in the body and can recognize the same 
antigen at a later date, even after several years. 
Non antigen specific cell-cell interaction 
This is also known as co-stimulation. If co-stimulation by other cell 
surface molecules does not occur following antigen presentation, the T 
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cell will not respond to the antigen and will undergo apoptosis or be 
rendered unresponsive to that antigen in the future (anergy). 
Effector functions of activated T cells 
Once the T cell is activated the next step is induction of 
inflammatory responses and tissue changes leading to the clinical picture 
of psoriasis. 
TNF-a is strongly implicated in the pathogenesis of psoriasis and 
psoriatic arthritis. TNF-a functions in a positive feedback loop by 
recruiting more inflammatory cells and upgrading receptors on those 
cells. TNF-a levels are markedly increased in skin lesions, synovium and 
serum of patients with psoriasis and these correlate with the severity of 
the disease. Decreased levels are associated with clinical resolution. 
 
DIAGNOSIS OF PSORIASIS 
There are no laboratory tests which will positively identify 
psoriasis. The blood count, Urine analysis, ESR and other hematologic 
chemical and serologic studies are within normal limits in most cases of 
psoriasis. 
The diagnosis of psoriasis is based upon: 
 
1. The family history of psoriasis 
2. The typical distribution of the lesions on the scalp, elbows, 
knees, the front of the legs, back and nails 
3. Well-defined non-indurated dry erythematous areas with silvery 
layer-upon-layer scaling 
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4. The candle – grease sign (when a psoriatic lesion is scratched 
with the point of a dissecting forceps, a candle-grease-like scale 
can be repeatedly produced even from the non-scaling lesions. 
This is CG sign) 
5. Auspitz sign (Complete removal of a scale produces pin-point 
bleeding) 
6. Koebner’s phenomenon (Psoriatic lesions may develop along 
the scratch lines in the active phase) 
7. Little or no itching 
8. History of previous attacks and seasonal variations of the 
disease 
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MATERIALS AND METHODS 
 This pilot study to evaluate the efficacy of NEERADIMUTHU 
VALLATHY MELUGU and KALAPAIKILANGU VELIPOOCHU 
(external) in treating kalanjaga padai (psoriasis) was carried out at Post 
Graduate Department of Sirappu maruthuvam, Government Siddha Medical 
College and Hospital,Palayamkottai. Under the observation and guidance of the 
head of the department. In this study totally 40 cases were taken out of which 
10 cases were taken from In patient ward and remaining 30 cases from out- 
patient ward. 
Selection of cases: 
  The patients were selected on the basis of the following inclusive 
criteria. 
 Age 15-60 yrs 
  Both male and female 
 Willing to give specimen of blood for the investigation whenever 
required. 
 Willing for admission and study in IPD for 48 days or willing to 
attend OPD 
 Patients with silvery white patches, coin shaped lesions, scaling 
with or without itching. 
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Diagnosis of the cases: 
            Diagnosis was made by conducting all the necessary investigation in 
siddha as well as in Modern medicine methodology. 
In siddha system the following aspect were taken into consideration. 
          1. Poriyal arithal 
 2. Pulanaal arithal 
 3. Vinaathal 
 4. Ennvagai Thervugal 
 5. Thinaigal 
 6. Paruva kalangal. 
The following investigations were done in Modern medicine aspect. 
Lab Investigation 
       Blood:    Total WBC count 
   Differential count of WBC 
   Erythrocyte sedimentation Rate 
   Hemoglobin percentage 
   Blood Sugar 
   Blood urea 
   Serum cholesterol (LDL&HDL) 
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 Urine: Albumin 
   Sugar 
   Deposit. 
     Motion:           Ova 
   Cyst 
Skin examination: 
                               Site- 
   Colour- 
   Size- 
   Shape-    
   Border 
   Itching 
   Erythema 
   Macule 
   Papule 
   Auspitz Sign  
   Koebner’s phenomenon 
   Candle Grease sign- 
Skin scrapping test for fungus. 
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SELECTION OF DRUG: 
              Selection of drug was made from the elaborate study of various siddha 
literatures and finally the drugs were selected from ANUBOGA VAITHIYA 
NAVANEETHAM PART- VIII,  GUNAPADAM MOOLIGAI VAGUPPU. 
       The Trial drugs 
  i) NEERADIMUTHU VALLATHY MELUGU as internal medicine 
and  
           ii) KALAPAIKILANGU VELIPOOCHU as external medicine. 
LINE OF TREATMENT: 
                The day before the trial started, vellai- ennai 15ml was given in early 
morning for purgation to correct the deranged vatham to all patients. 
From the second day onwards the trial drugs are administrated. 
 i) NEERADIMUTHU VALLATHY MELUGU as Internal medicine 
 ii) KALAPAIKILANGU VELIPOOCHU as external medicine 
- This powder was given only for external use on the lesions. 
        All the patients were advised to strict dietary regimen (or) pathiyam to 
avoid interaction with drug. 
       Some complementary therapies like Pranayamam and simple yogasana 
were advised. 
 70 
Clinical assessment: 
- The drugs were subjected to bio-chemical and pharmacological 
analysis. 
- Required information will be collected from each patient by using 
the forms mentioned in protocol. 
- For I.P patients, the clinical assessments will be made daily and 
recorded in the appropriate forms. 
- For O.P patients in each visit the clinical assessment will be 
recorded regularly. 
- An individual case sheet was maintained for each and every 
patient. 
- The laboratory investigation will be done before and after 
treatment and recorded in the appropriate from 
- All the patients were screened for side effects and adverse effects. 
- The outcome is assessed by the reduction of severity of symptoms 
and the results are observed. 
- All the patients were advised for the further follow –up.  
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OBSERVATION AND RESULTS 
The observation and results were studied and tabulated under the 
following headings: 
1. Family History 
2. Sex distribution 
3. Age distribution 
4. Kaalam distribution 
5. Occupational status 
6. Diet habit 
7. Paruva Kaalam 
8. Thinai reference 
9.  Socio-economic status 
10. Triggering factors 
11. Clinical features 
12. Other general clinical features 
13.  Distribution of three doshas 
14.  Udar kattugal reference 
15.  En vagai thervugal 
16.  Neerkkuri, Neikkuri reference 
17. Assessment of results after Treatment 
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1. FAMILY HISTORY 
Sl. No Criteria No of Cases Percentage 
1.  Family History (+ve) 12 30% 
2.  Family History (-ve) 28 70% 
 
 
 
      
 Observation 
 It is observed that 30% of the patients showed positive family history. 
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2.  SEX DISTRIBUTION 
Sl No Sex No of Cases Percentage 
1 Male 23 57.25% 
2 Female 17 42.75% 
 
 
 
 
Observation 
Among the 40 patients selected for this study, 57.25% were males and 
42.75% were females. 
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3. AGE DISTRIBUTION 
Sl. No Age No of Cases Percentage 
1 
Below 20 and 
21-30 
8 20% 
2 31-40 10 25% 
3 41-50                 11 27.50% 
4 51-60 & above 11 27.50% 
 
            
 
 
Observation 
The patients selected were from all age groups as given above and the 
maximum number of patients was in the age between 41-50 and also in 51-60 
& above. 
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4 . KAALAM DISTRIBUTION 
In Siddha literature human life has been divided into three periods as 
follows 
1 Vatham 
2 Pitham 
3 Kabam 
The duration of each period is said to be 33 years 
Sl No Kaalam No of Cases Percentage 
1 Vatha Kaalam (1-33 Years) 11 27.5% 
2 Pitha Kaalam (34-66 years) 27 67.5% 
3 Kaba Kaalam (67-100 years) 2 5% 
 
 
Observation 
Out of 40 patients, 27 patients reported were in Pitha kaalam, 11 were in 
Vatha kaalam and  the remaining 2 in kaba kalam. 
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5. OCCUPATIONAL STATUS 
Sl. No Nature of Work No. of Cases Percentage 
1 Home Maker 7 17.50% 
2 Farmer 5 12.50% 
3 Cooli 6 15.00% 
4 Business 2 5.00% 
5 Engineer 2 5.00% 
6 Student 5 12.50% 
7 Teacher 2 5.00% 
8 Other manual workers 11 27.5% 
 
 
Observation 
The patients selected for the study belongs to various occupational status 
and no particular association was found. 
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6.  DIETARY HABITS 
Sl. No Dietary Habits No of Cases Percentage 
1 Vegetarian 4 10% 
2 Mixed diet 36 90% 
 
 
 
 
Observation 
All the cases except four were mixed diet. 
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7. PARUVA KAALAM 
Sl 
No. 
Paruva Kaalam No. of Cases Percentage 
1 
Kaar kaalam (Aavani & Purattasi) 
(Aug 16 – Oct 15) 
24 60% 
2 
Koothir Kaalam (Aippasi & Kaarthigai) 
(Oct 16 – Dec 15) 
2 5% 
3 
Munpani Kaalam (Margazhi & Thai) 
(Dec 16 – Feb15) 
0 0.00% 
4 
Pinpani Kaalam (Maasi & Panguni) 
(Feb 16 – Apr 15) 
0 0.00% 
5 
Elavenil Kaalam (Chithirai & Vaikasi) 
(Apr 16 – June 15) 
0 0.00% 
6 
Muthuvenil Kaalam (Aani & Aadi) 
(June 16 – Aug 15) 
14 35% 
 
 
 
Observation  :       
Among the 40 patients admitted for this study, 24 patients reported in 
kaar Kaalam, 2 patients in koothir kaalam and 14 in mudhuvenil kaalam. 
 79 
 
8. THINAI REFERENCE 
Sl. No Thinai No. of Cases Percentage 
1 Kurinji (Hill Area) 1 2.50% 
2 Mullai (Forest Area) 0 0.00% 
3 Marutham (Fertile Land) 32 80.00% 
4 Neithal (Coastal Area) 7 17.50% 
5 Paalai (Desert Land) 0 0.00% 
 
 
 
Observation 
80% of the patients were from Marutham (Fertile Land) and 17.5% were 
from Neithal (costal area) and the remaining 2.5% from Kurinji nilam(hill 
area). 
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9.  SOCIO-ECONOMIC STATUS 
Sl. No. Economic Status No of Cases Percentage 
1 Poor 20 50% 
2 Middle Class 10 25% 
3 Rich 10 25% 
 
 
 
Observation 
50% of the patients were poor and 25% of patients were from middle 
class and the remaining 25% belongs to rich groups. 
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10.TRIGGERING FACTORS: 
 
 
Observation: 
                    Among 40 patients, 50% of them had unknown triggering factor, 
while 17.5% had smoking as the factor, 12.5% were due to psycho-somatic 
cause.  
Sl. No Triggering factors No of Cases Percentage 
1 Infection 0 0% 
2 Reaction to certain medicine 0 0% 
3 Skin injury 2 5% 
4 Psycho-somatic 5 12.5% 
5 Alcohol 4 10% 
6 Smoking 7 17.5% 
7 Unknown 20 50% 
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11. CLINICAL FEATURES 
Sl. No Clinical Features No of Cases Percentage 
1 Red patches with ivory Scaling 40 100% 
2 Itching 20 50.00% 
3 Scalp lesions 8 20.00% 
4 Auspitz sign 40 100% 
5 Candle Grease sign 15 37.50% 
6 Koebner’s Phenomenon 40 100% 
7 Nail changes 5 12.50% 
8 Palm and sole lesions 5 12.50% 
9 Joint involvement 6 15.00% 
 
 
Observation: 
 All the patients have scaling, Auspitz sign, Koebner’s Phenomenon as 
their predominant symptom. 
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12. OTHER GENERAL CLINICAL FEATURES: 
Sl. No Clinical features No. Of cases Percentage 
1.  Constipation 4 10% 
2.  Cough 2 5% 
3.  Insomnia 2 5% 
4.  Loss of appetite 2 5% 
5.  Anemia 12 30% 
 
Among 40 patients, 4 had constipation, 2 had cough, 2 had sleep 
disturbances, 2 had loss of appetite, and 12 were anemic. 
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13. DISTRIBUTION OF MUKKUTRAM 
The derangement of Vatham, Pitham and Kabam in Kalanjaga padai is 
as follows 
VATHAM 
Sl. No Classification of Vatham No of Cases Percentage 
1 Pranan 0 0.00% 
2 Abanan 4 10.00% 
3 Udhanan 0 0.00% 
4 Samanan 40 100.00% 
5 Viyanan 40 100.00% 
6 Nagan 0 0.00% 
7 Koorman 0 0.00% 
8 Kirukaran 2 5.00% 
9 Devathathan 2 5.00% 
10 Dananjayan 0 0.00% 
          
 
Observation: 
Samanan and Viyanan were found to be affected in all the 40 patients. 
Abanan, Kirukaran and Devathathan were affected in  4, 2 and 2 patients 
respectively. 
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PITHAM 
Sl. No Classification of Pitham No. of Cases Percentage 
1 Anarpitham 2 5.00% 
2 Ranjakam 12 30.00% 
3 Sathakam 6 15% 
4 Alosakam 0 0.00% 
5 Prasakam 40 100.00% 
 
 
Observation: 
Prasakam was affected in all the cases. Sathakam was found affected in 
15% of the patients, Ranjakam was affected in 30% of the patients and 
Anarpitham in 5% of the patients. 
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KABAM 
Sl. No Classification of Kabam No of Cases Percentage 
1 Avalambagam 6 15% 
2 Kilethagam 2 5.00% 
3 Pothagam 2 5.00% 
4 Tharpagam 0 0.00% 
5 Santhigam 6 15% 
               
 
 
Observation: 
Avalambagam and Santhigam were found to be affected in 15% of the 
patients and then in 5% of the patients Kilethagam and pothagam were found to 
be affected. 
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14. UDAL KATTUGAL 
Sl. No Udar Kattugal No of Cases Percentage 
1 Saaram 40 100% 
2 Senneer 38 95% 
3 Oon 40 100% 
4 Kozhuppu 2 5% 
5 Enbu 6 15% 
6 Moolai 0 0% 
7 Sukkilam/Suronitham 0 0% 
 
] 
 
Observation: 
Among 40 patients, Saaram and Oon were affected in all the cases and 
Senneer in 38 patients. Enbu was seen affected in 6 patients and Kozhuppu in 2 
patients. 
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15. EN VAGAI THERVUGAL 
Sl. No En Vagai Thervugal No. of Cases Percentage 
1 Naa 0 0% 
2 Niram 40 100% 
3 Mozhi 0 0% 
4 Vizhi 12 30% 
5 Sparisam 40 100% 
6 Malam 4 10% 
7 Moothiram 0 0% 
8 Naadi 
 a. Vathapitham 18 45.00% 
 b. Vathakabam 15 37.50% 
 c.  Pithakabam 7 17.50% 
 
 
In En vagai thervugal, Niram and Sparisam were found affected in all 
the 40 cases. Vizhi was affected in 30 % of the patients. The Naadi nadai seen 
in Kalanjaga padai patients were Vathapitham 45 %, Vathakabam 37.50 % and 
Pithakabam 17.50%. 
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16. NEERKKURI, NEIKKURI REFERENCE  
Sl. 
No 
Type of Test No. of Cases Percentage 
1 
Neerkkuri: 
“Vaikkol Niram”  (straw yellow) 
40 100% 
NEIKKURI:   
a) (Vatham)  “Aravena Neelal” 18 45.00% 
b) (Pitham) “Aazhi pol 
Paraval” 
8 20.00% 2 
c) (Kabam) “Muththothu 
Nitral” 
14 35.00% 
 
 
Observation: 
 Neerkuri showed vaikkol niram in all the patients. Neikkuri showed 
vatha kuri among 45% patients, Pitha kuri in 20% patients and kaba kuri in 
35% patients.  
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17. ASSESSMENT OF RESULTS: 
CLASSIFICATION OF PSORIASIS BASED ON THE SEVERITY OF 
SYMPTOMS: 
1. Severe     -Marked plaque elevation, Scaling and / or erythema / affecting 
more than 10% of the body surface 
2. Moderate – Moderate plaque elevation, Scaling and / or erythema / 
affecting 3-10 % of the body surface 
3. Mild – Slight plaque elevation, scaling and or erythema / affecting less 
than 3% of the body surface 
4. Clear - No signs of psoriasis 
- F. Alzeni et al., (2011) 
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F). OVERALL RESULTS AFTER TREATMENT 
                Based on the outcome, all the 40 patients have been classified into 4 
grades. The gradation is as follows, 
 Grade I (Good Improvement) - No signs of psoriasis (post 
inflammatory hyper-pigmentation may be present)  
 Grade II (Moderate Improvement) - Slight plaque elevation, 
reduction in size of all lesions, mild scaling, itching and/or erythema  
 Grade III (Mild Improvement) - no new lesions, moderate plaque 
elevation, scaling, itching and/or erythema  
 Grade IV (No Improvement) - very marked plaque elevation, 
scaling, itching and/or erythema with or without new lesions 
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Observation: 
                      In this study 67.5% of the patients had good improvement, 25% 
of the patients had moderate improvement, 7.5% of them   had mild prognosis. 
 
Sl. No Effect of therapy No. of Cases Percentage 
1 Good Improvement 27 67.5 
2 Moderate Improvement 10 25 
3 Mild Improvement 3 7.5 
4 No Improvement 0 0 
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OP AND IP CASES CLINICAL IMPROVEMENT 
Sl. 
No 
OP & 
IP NO 
NAME AGE SEX DOA DOD 
TREAT
ED 
DAYS 
RESULT 
1 50111 MANIVASAGAM 20 M 4.7.12  24.8.12 42 GOOD 
2 53993 MUTHULAKSHMI 22 F 17.7.12 7.9.12 56 GOOD 
3 55922 MARIAMMAL 38 F 24.7.12 17.9.12 56 MODERATE 
4 58197 ARUMUGANAIN
AR 
35 M 31.7.12 3.10.12 56 GOOD 
5 63057 ASIA BEGAM 43 F 16.8.12 10.1012 35 MODERATE 
6 58193 KANDAN 50 M 31.7.12 7.9.12 35 GOOD 
7 51871 VENGATACHALA 79 M 10.7.12 25.9.12 56 GOOD 
8 63020 SARADHA 45 F 16.8.12 12.11.12 42 GOOD 
9 69642 KANDHASAMY 52 M 7.9.12 5.10.12 35 GOOD 
10 73033 RAJAM 78 F 7.9.12 2.11.12 35 MODERATE 
11 65185 PRABAKAR 19 M 24.8.12 25.9.12 35 GOOD 
12 60009 KUTTYDURAI 40 M 6.8.12 20.9.12 42 GOOD 
13 65400 MARIAMMAL 55 F 25.8.12 18.9.12 28 MODERATE 
14 56915 PERIASAMY 60 M 27.7.12 21.9.12 56 GOOD 
15 58983 MOHAMED 
MAIDEEN 
53 M 3.8.12 10.9.12 42 GOOD 
16 57078 SUNDAR 43 M 27.7.12 7.9.12 49 MODERATE 
17 60008 RATHINAM 40 F 6.8.12 14.9.12 35 GOOD 
18 64587 E.SHIVA 20 M 20.8.12 9.10.12 42 GOOD 
19 64040 SANTHIYA 10 FC 21.8.12 9.10.12 56 GOOD 
20 51986 KRISHNASAMY 46 M 10.7.12 7.9.12 56 GOOD 
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OP AND IP CASES CLINICAL IMPROVEMENT 
Sl. 
No 
OP & IP 
NO 
NAME AGE SEX DOA DOD 
TREATED 
DAYS 
RESULT 
21 68376 MAHORAN 39 M 4.9.12 9.10.12 42 GOOD 
22 70829 ELANGO 48 M 11.9.12 1.11.12 42 GOOD 
23 74837 PAPPURANI 22 F 7.10.12 27.10.12 28 MILD 
24 77487 KANAGALAKSHM
I 
25 F 1.10.12 27.10.12 28 MODERATE 
25 66735 LAURENCE 59 F 29.8.12 15.11.12 56 GOOD 
26 75490 ARUMUGA 
NAINAR 
50 F 3.9.12 27.10.12 35 MODERATE 
27 78957 N.MURUGAN 40 M 4.10.12 27.10.12 28 GOOD 
28 70162 LAKSHMI 62 F 8.9.12 17.11.12 36 GOOD 
29 78891 SHOBIYA 32 F 4.10.12 29.11.12 56 GOOD 
30 66068 GANESAN 45 M 27.8.12 8.10.12 35 GOOD 
31 93726 RAJNABANU 15 F 19.11.12  28 MODERATE 
32 84230 PECHUMUTHU 53 M 22.10.12 30.11.12 35 GOOD 
33 79024 RAMACHANDRAN 32 M 5.10.12 30.11.12 56 GOOD 
34 28831 ANNAMMAL 72 F 31.8.12 14.9.12 15 MODERATE 
35 26842 KARUPASAMY 47 M 14.8.12 12.9.12 30 GOOD 
36 29243 SUBHULAKSHMI 35 F 5.9.12 20.9.12 17 MODERATE 
37 26404 SWAMINATHAN 56 M 10.8.12 8.9.12 23 GOOD 
38 30885 SANTHANA 
KUMAR 
50 M 17.9.12 28.9.12 12 MILD 
39 27436 MARISAMY 66 M 21.8.12 26.9.12 36 GOOD 
40 30227 GANESAN 39 M 11.9.12 19.9.12 10 MILD 
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BLOOD INVESTIGATIONS BEFORE AND AFTER TREATMENT- OP & IP PATIENTS 
DC ESR Bl.Sugar Bl.Urea Se. Cr 
TC 
N L E M F PP 
S. 
NO 
0P. 
NO 
BT AT BT AT BT AT BT AT BT AT 
BT AT 
BT AT BT AT 
BT AT BT AT 
1. 5011 7500 8000 51 50 46 45 3 1 - - 1/6 ¼ 68 70 103 100 22 20 0.8 0.8 
2. 53993 9200 9500 65 66 30 31 5 4 0 0 1/10 ¼ 95 93 140 135 18 20 0.8 0.9 
3. 55922 8500 8500 60 62 34 34 6 4 - - 1/7 ¼ 87 85 105 110 21 20 0.7 0.9 
4. 58197 9000 9200 65 66 33 34 1 1 1 1 ½ 1/1 103 104 109 129 20 20 0.8 0.7 
5. 63057 8200 8500 58 57 30 32 10 6 2 1 ¼ ½ 110 105 121 109 24 25 1 0.9 
6. 58193 8600 8500 61 62 35 35 4 2 - - ½ 1/1 75 80 131 130 23 22 0.6 0.7 
7. 51871 9900 9500 60 61 36 35 4 1 - - ¼ ½ 60 62 96 110 21 20 0.7 0.8 
8. 63020 7900 7800 65 66 32 33 2 - 1 1 1/10 1/6 89 90 92 114 16 17 0.6 0.6 
9. 69642 8000 8500 61 60 31 30 7 2 1 1 1/8 ½ 98 100 110 130 27 25 0.8 0.8 
10. 73033 7500 8000 60 61 29 31 10 4 1 1 ¼ ½ 80 82 110 112 25 26 0.9 1 
11. 65185 9000 9200 63 62 33 33 4 1 - - 1/8 ½ 91 90 138 110 15 14 0.7 0.7 
12. 60009 9000 9100 68 69 28 26 4 1 - - 1/10 ¼ 102 103 130 110 18 18 0.6 0.7 
13. 65400 8900 9000 64 65 32 33 4 2 - - 1/16 ¼ 64 65 124 110 14 15 0.7 0.7 
14. 56915 9200 9200 72 72 26 27 2 - - - 1/10 ¼ 65 63 66 66 12 13 0.5 0.6 
15. 58983 8700 8800 66 65 30 32 4 1 - - 1/6 ½ 105 105 98 98 27 26 0.9 0.8 
16. 57078 9200 9200 65 66 32 32 3 1 - - 1/8 ½ 182 166 132 132 23 23 0.8 0.8 
17. 60008 8700 8600 55 67 30 32 15 6 - - ½ 1/1 129 125 153 150 16 15 0.6 0.7 
18. 64587 9000 9100 58 60 28 29 14 5 - - 1/8 ¼ 74 78 132 130 17 17 0.8 0.8 
19. 64040 7900 8000 67 65 30 28 3 1 - - ¼ ½ 86 88 110 125 14 14 0.7 0.8 
20. 51986 7900 8000 57 57 40 38 3 1 - - ¼ ½ 89 90 83 120 13 14 0.9 1 
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BLOOD INVESTIGATIONS BEFORE AND AFTER TREATMENT – OP & IP PATIENTS 
DC ESR Bl. Sugar Bl. Urea Se. Cr 
TC 
N L E M F PP 
S. 
NO 
IP. NO 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
21. 68376 8000 8500 61 63 31 30 8 2 - - 1/8 ½ 98 95 120 115 27 25 0.8 0.9 
22. 70829 9500 9500 69 67 27 28 4 2 - - ½ ½ 68 80 102 110 20 21 0.6 0.7 
23. 74837 7500 8000 65 68 31 31 3 1 1 1 1/8 1/8 80 85 120 115 22 22 0.8 0.8 
24. 77487 8000 8500 62 61 34 32 2 1 2 1 ½ ¼ 88 90 80 80 24 25 0.8 0.9 
25. 66735 9900 9600 65 68 25 30 8 2 1 1 ¼ 1/6 94 98 95 120 17 16 0.8 0.8 
26. 75490 8,900 9000 65 66 32 32 6 1 - - ¼ ¼ 91 96 80 115 21 20 0.7 0.6 
27. 78957 7500 8000 61 62 36 36 2 1 1 1 ½ 1/6 100 96 110 110 22 23 0.9 0.8 
28. 70162 9,000 9500 65 65 31 32 4 1 - - 1/6 ½ 112 108 125 125 29 30 0.7 0.9 
29. 78891 7900 8000 65 68 32 33 3 1 - - ½ 1/1 68 66 80 115 15 16 0.8 0.8 
30. 66068 7000 7500 58 60 40 42 2 - - - ¼ ½ 89 92 98 95 16 15 0.8 0.8 
31. 93726 8500 9000 65 68 29 32 6 2 - - 1/6 ½ 95 100 130 125 22 23 0.9 1 
32. 84230 8000 8500 64 65 30 32 6 2 - - ½ 1/1 87 89 112 118 25 26 0.7 0.8 
33. 79024 9800 9900 69 68 28 30 3 1 - - ½ 1/1 85 90 140 135 21 22 1 0.8 
34. 2883 8000 8500 61 62 33 33 6 2 - - 1/8 ½ 111 109 140 135 25 22 0.8 0.9 
35. 2684 7500 8000 49 50 49 48 2 1 - - 1/20 1/86 93 100 80 90 16 17 0.9 0.8 
36. 2924 7900 8000 65 66 29 32 6 2 - - 1/50 1/10 146 140 88 90 17 18 0.7 0.7 
37. 2640 7000 7500 67 68 30 33 3 1 - - 1/6 ½ 67 70 100 110 20 21 0.8 0.9 
38. 3088 6100 6500 61 62 37 36 2 - - - 1/8 ¼ 71 80 115 125 18 19 0.7 0.8 
39. 2743 8100 8500 67 68 28 32 5 2 - - ¼ ½ 85 90 85 120 21 22 0.9 0.8 
40. 3022 8700 9000 66 67 28 30 6 2 - - 1/22 1/6 69 75 90 130 14 15 0.6 0.7 
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URINE AND MOTIONS EXAMINATION BEFORE AND AFTER TREATMENT – OP & IP PATIENTS 
URINE MOTION 
Before Treatment After Treatment Before Treatment After Treatment 
Deposits Deposits 
S. 
NO 
IP 
NO 
Albumin Sugar Pus 
Cells 
Epi. 
cells 
Albumin Sugar Pus 
cells 
Epi. 
cells 
Ova Cyst 
Occult 
blood 
Ova Cyst 
Occult 
blood 
1. 5011 NIL NIL 1-2 NIL NIL NIL 2-4 1-2 NIL NIL NIL NIL NIL NIL 
2. 53993 NIL NIL NIL NIL NIL NIL 0-1 0-1 NIL NIL NIL NIL NIL NIL 
3. 55922 NIL NIL 1-2 1-2 NIL NIL 1-2 1-5 NIL NIL NIL NIL NIL NIL 
4. 58197 NIL NIL 2-4 2-3 NIL NIL 2-3 1-2 NIL NIL NIL NIL NIL NIL 
5. 63057 NIL NIL 1-2 2-3 NIL NIL 1-2 2-4 NIL NIL NIL NIL NIL NIL 
6. 58193 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
7. 51871 NIL NIL 4-5 2-4 NIL NIL 2-4 2-4 NIL NIL NIL NIL NIL NIL 
8. 63020 NIL NIL 1-2 1-2 NIL NIL 2-3 0-1 NIL NIL NIL NIL NIL NIL 
9. 69642 NIL NIL 2-3 2-3 NIL NIL 0-1 0-2 NIL NIL NIL NIL NIL NIL 
10. 73033 NIL NIL 1-2 1-2 NIL NIL 0-1 0-1 NIL NIL NIL NIL NIL NIL 
11. 65185 NIL NIL NIL NIL NIL NIL 1-2 2-4 NIL NIL NIL NIL NIL NIL 
12. 60009 NIL NIL 1-2 1-2 NIL NIL 1-3 1-5 NIL NIL NIL NIL NIL NIL 
13. 65400 NIL NIL 1-2 2-4 NIL NIL 2-4 2-4 NIL NIL NIL NIL NIL NIL 
14. 56915 NIL NIL 2-4 2-3 NIL NIL 1-5 0-1 NIL NIL NIL NIL NIL NIL 
15. 58983 NIL NIL 1-2 1-2 NIL NIL 1-2 2-4 NIL NIL NIL NIL NIL NIL 
16. 57078 NIL NIL 1-2 2-3 NIL NIL 1-4 1-3 NIL NIL NIL NIL NIL NIL 
17. 60008 NIL NIL NIL NIL NIL NIL 0-1 0-1 NIL NIL NIL NIL NIL NIL 
18. 64587 NIL NIL 1-2 1-2 NIL NIL 1-2 2-4 NIL NIL NIL NIL NIL NIL 
19. 64040 NIL NIL 2-4 2-3 NIL NIL 1-3 1-3 NIL NIL NIL NIL NIL NIL 
20. 51986 NIL NIL 1-2 1-2 NIL NIL 2-4 2-4 NIL NIL NIL NIL NIL NIL 
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URINE AND MOTIONS EXAMINATION BEFORE AND AFTER TREATMENT – OP & IP PATIENTS 
URINE MOTION 
Before Treatment After Treatment Before Treatment After Treatment 
Deposits Deposits 
S. 
NO 
OP 
NO 
Albumin Sugar Pus 
Cells 
Epi. 
cells 
Albumin Sugar Pus 
cells 
Epi. 
cells 
Ova Cyst 
Occult 
blood 
Ova Cyst 
Occult 
blood 
21. 68376 NIL NIL 1-2 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
22. 70829 NIL NIL 1-2 1-2 NIL NIL 0-1 0-2 NIL NIL NIL NIL NIL NIL 
23. 74837 NIL NIL NIL NIL NIL NIL 0-2 0-1 NIL NIL NIL NIL NIL NIL 
24. 77487 NIL NIL 2-4 1-4 NIL NIL 1-2 0-4 NIL NIL NIL NIL NIL NIL 
25. 66735 NIL NIL 1-5 1-2 NIL NIL 2-4 2-4 NIL NIL NIL NIL NIL NIL 
26. 75490 NIL NIL 1-2 1-2 NIL NIL 1-4 1-2 NIL NIL NIL NIL NIL NIL 
27. 78957 NIL NIL 2-4 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
28. 70162 NIL NIL 1-2 1-2 NIL NIL 2-4 2-4 NIL NIL NIL NIL NIL NIL 
29. 78891 NIL NIL 4-5 2-4 NIL NIL 2-5 2-3 NIL NIL NIL NIL NIL NIL 
30. 66068 NIL NIL 1-2 1-2 NIL NIL 1-3 1-2 NIL NIL NIL NIL NIL NIL 
31. 93726 NIL NIL 1-2 1-3 NIL NIL 0-5 0-4 NIL NIL NIL NIL NIL NIL 
32. 84230 NIL NIL 2-4 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
33. 79024 NIL NIL 2-4 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
34. 2883 NIL NIL 1-2 1-2 NIL NIL 2-4 2-4 NIL NIL NIL NIL NIL NIL 
35. 2684 NIL NIL NIL NIL NIL NIL 2-3 2-3 NIL NIL NIL NIL NIL NIL 
36. 2924 NIL NIL 2-4 2-4 NIL NIL 2-4 1-2 NIL NIL NIL NIL NIL NIL 
37. 2640 NIL NIL 2-4 1-2 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
38. 3088 NIL NIL 1-2 1-3 NIL NIL 0-1 0-1 NIL NIL NIL NIL NIL NIL 
39. 2743 NIL NIL 1-2 1-4 NIL NIL 0-5 0-4 NIL NIL NIL NIL NIL NIL 
40. 3022 NIL NIL 3-5 2-4 NIL NIL 1-2 1-2 NIL NIL NIL NIL NIL NIL 
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DISCUSSION 
Psoriasis is a common, chronic and non-infectious skin disease 
characterized by well defined slightly raised dry erythematous macules with 
silvery scales and typical extensor distribution. Physically it is a most 
uncomfortable disease. Psoriasis patients are humiliated, disgraced and tend to 
hide their skin from the critical public. The psychological impact of feeling of 
self consciousness, frustration and shame often leads to severe mental 
depression. Remissions and relapse of this disease is quite common and there is 
no specific treatment available in other systems of medicines. With this 
background the disease psoriasis which is correlated with kalanjaga padai in 
siddha literature was chosen for the dissertation work. 
As an attempt in fulfilling the aim, the internal and external medicines 
for treating the disease kalanjaga padai were selected. 
The trial drugs selected were  
i. Neeradi muthu vallathy melugu as the internal medicine 
ii) Kalaipai kilangu velipuchu as the external medicine 
In order to attain the primary objective of the study the result of the 
efficacy of trial drugs with observed and tabulated. 
The secondary objectives of the study were reached by studying the 
disease kalanjaga padai under various headings like gender distribution, age 
distribution, kaalam, thinai etc. The results were observed and documented. All 
the observations are discussed here under. 
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Family History 
 In this study 30% of the patients had strong family history. Many recent 
studies also shows the coincidence to this fact. 
 F-Valenzuela et al., (Dec-2011) study results exactly coincides with the 
results inferred in this study. 
Sex distribution 
 More or less Equal numbers of male and female patients were 
voluntarily selected for this study. So the inference obtained had no statistically 
significant data upon sex distribution. 
Age distribution: 
            The maximum number of patients was in the age between 41-50 and 
also in 51-60 & above. 
Kaalam: 
 The higher incidence was found to be in pitha kaalam (34-66 years). 
Occupational status 
 From the observed result it was clear that there was no association 
between the occupational status and the psoriasis incidence. 
 Luigi Naldi, M.D et al., (2007) also documented the same result in his 
study. 
Dietary habits: 
36 patients were reported to have mixed diet. So this data had no 
statistically significant data. 
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Paruva kaalam: 
From the tabulated data, it was shown that 24 patients reported in 
kaarkaalam, 2 patients in koothir kaalam and 14 in mudhuvenil kalam 
Actually the study period started from June and ended in January. So the 
obtained result may not have a scientific value to influence the disease and a 
long period study is required to evaluate the seasonal variations. 
Thinai Reference: 
 The inferred result shows that incidence was highest in Marutha nilam. 
As this study is a single centered study, the inferred results may not have 
a significant evaluation of influence of thinai on psoriasis. 
Socio- economic status: 
Here 50% were reported to be poor and 25% from middle class and 25% 
were rich. The relation between psoriasis incidence and socio economic status 
was likely to be complicated. The inferred result was not statistically 
significant. 
Triggering factors: 
From the observed results it was proved that the smoking (17.5%) and 
the psycho-somatic disorder (12.5%) plays a key role as an important 
Triggering factors. 
The result inferred coincides with the previous studies like Danielle 
Levine. BA et al., (1999) and Michelle Badash MS. et al., (2008). 
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Clinical features: 
All the patients had patches with ivory scaling, Auspitz sign and 
Koebner’s phenomenon as their predominant clinical features. 
And some patients had itching and candle grease sign as their second 
predominant features. Further nail was found affected in 5 patients and 6 cases 
had joint involvement. 
Distribution of three dhosas: 
a) Vatham: 
Samanan and viyanan were found to be affected in all 40 patients. 
b) Pitham: 
Prasakam was affected in all the cases. 
c) Kabam: 
Santhigam (psoriatic arthritis) was found to be affected in 15% of the 
patients. 
En vagai thervugal 
Niram and sparisam were found affected in all the 40 cases. 
In naadi nadai, vatha pitha nadai (45%) predominates among the other 
naadi nadai in the psoriatic patients. 
Udal Kattugal 
Among the seven udal kattugal saaram and Oon were affected in all the 
cases and enbu (Psoriatic arthritis) were affected in 15% of the cases. 
 103 
Laboratory investigations were done for all the cases before and after 
treatment. There were no significant variations in the laboratory investigation 
except in certain aspects like ESR and HB 
The phytochemical analysis of Neeradi muthu vallathy melugu had 
shown the presence of calcium, sulphate, Iron (ferrous), Starch, unsaturated 
compounds, reducing sugar and amino acid. 
Pharmacological studies of Neeradi muthu vallathy melugu shows 
significant analgesic and anti-inflammatory properties. And the external 
medicine kalapai kilangu velipuchu also shows significant acute anti-
inflammatory properties. 
Treatment: 
In siddha system of medicine the line of treatment primarily aimed to 
retain the deranged doshas and then providing relief from symptom. So before 
treatment each patient was advised for purgation by giving vellai ennai-15 ml 
with hot water during morning for first day treatment. 
From the second day onwards Internal Medicine- Neeradi muthu 
vallathy melugu 5 gm in 3 divided doses and External Medicine- kalapai 
kilangu velipuchu were administrated during treatment, the patients were 
advised to follow pathiyam (avoid tamarind, tubers etc) and patients were 
advised to avoid foods which induces itching. 
Along the course of the treatment some of the complementary methods 
which were already planned like pranayama, asana and mudras were instructed 
to the patients. 
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The outcome is mainly assessed by reduction in symptoms like itching 
and scaling. 
No adverse effects of both internal and external medicine were noted 
along the course of the treatment clinically. 
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SUMMARY 
The disease Psoriasis was comparatively studied with the disease 
Kalanjaga padai. In considering the following three important facts that, 
Psoriasis has been linked to an increased risk of stroke and atrial 
fibrillation (ole Ahuhoff et al., 2011), its important complication in many 
patients is psoriatic arthritis (Gelfand IM et al., 2005) and Long term 
toxicities are observed with all currently available system treatments 
(European Medicine agency Journal), it is a need to evaluate the safe and 
effective drug for the treatment of psoriasis. For this a clinical trial with 
internal medicine Neeradi muthu vallathy melugu and external 
medicine kalapai kilangu velipoochu in meeting the disease psoriasis 
was conducted. 
For this 40 cases were selected. The pre clinical studies of the trial 
drug were found to be encouraging.   
Out of 40 cases 30 were treated in OPD and remaining 10 in IPD 
of Govt. Siddha Medical College & Hospital Palayamkottai. Some of the 
complementary therapies were followed along the course of the 
treatment. Complete proforma was maintained for each and every patient. 
Daily progress was observed to note the clinical efficacy of the drug. The 
results obtained were found to be auspicious. 
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Pre clinical pharmacological analysis of the trial drug had  
 Significant anti histamine action. 
 Significant acute anti inflammatory actions. 
 Moderate chronic anti-inflammatory actions. 
 
 Significant analgesic action 
 
No adverse reactions like nausea, vomiting, diarrhoea, abdominal 
discomfort, drowsiness were reported during the study period. Hence the 
trial drug was found to be safe and effective. 
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CONCLUSION 
In this clinical study “Neeradi muthu vallathy melugu” and “kalapai 
kilangu velipuchu” were taken as Internal & External drug respectively for 
treating the disease Kalanjaga padai. 
In the pre clinical study Pharmacological evaluation of the trial drugs shows 
 Significant anti histamine effects 
 Significant acute anti inflammatory effects 
 Moderate chronic anti inflammatory effects 
 Significant analgesic action 
The Overall results of  efficacy of the trial drugs along with 
complementary therapies by reducing the clinical signs and symptoms like 
Itching, Scaling and erythema in this Clinical study were  found to be Good in 
67.5% cases, Moderate in 25% cases and Mild in 7.5%.  
The costs of the trial medicines are relatively economical. The raw 
drugs are easily available and the preparation is also convenient. No adverse 
effects and side effects were found clinically for the trial drugs.  
So the study proved conclusively that the clinical effects of the trial drugs were 
found to be good in treating the disease Psoriasis. 
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ANNEXURE I 
STANDARD OPERATING PROCEDURE FOR PREPARATION OF 
”NEERADIMUTHU VALLATHY MELUGU (Internal)”   AND 
”KALAPAIKILANGU VELIPOOCHU (External) ” : 
INTERNAL MEDICINE: 
NEERADIMUTHU VALLATHY MELUGU 
INGREDIENTS:  
Serangottai(seeds of semicarpous anardica)   -3500gms 
Neeradimuthu((seeds of hydnocarpous laurifolia)  -350gms 
Parangipattai(barks of smilax chinensis)    -350gms 
Pirapankilangu(rhizome of calamus rotang)   -70 gms 
Karunjeeragam(seeds of Nigella sativa)    -70 gms 
Seeragam(seeds of cuminum cyminum)    -70 gms 
Pieces of fried vasambu(acorus calamus)    -70 gms 
Sivanarvembu(indigofera asplathoides)    -70 gms 
Sanganverpattai(root barks of azima tetracantha)  -70 gms 
Kollankovai kilangu (rhizome of corollocarpus epigaeus) -70 gms 
Amukkara kilangu(rhizome of withania somenifera)  -70 gms 
Vellarugu(enicostema axillare)     -70 gms 
Errukanver pattai(root barks of calotrophis gigantea)  -70 gms 
Athipattai(barks of ficus racemosa)    -70 gms 
Kumilam verpattai(root bark of gmelina arbora)   -70 gms 
Sathisaranai kilangu (rhizome of trianthema decandra)  -70 gms 
Milagaranai kilangu (rhizomes of toddalia asaitica)  -70 gms 
Senthotti pattai(barks of Pavonia odorata )   -70 gms 
Veppankottai paruppu(seeds of azhadirecta indica)  -70 gms 
Vetpalai arisi (seeds of wrightia tinctoria)   -70 gms 
Thurusu(purified copper sulphate)     -17 ½ gms 
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Paal thutham(purified zinc)     -17 ½ gms 
Purified kanthagam(sulphur)     -17 ½ gms 
Purified rasam(mercury)      -17 ½ gms 
Ellu(seeds of sesamum plants)     -280 gms 
Panjaggery        -1400 gms 
 
PREPARATION: 
a) 3500 gms of semecarpus anacardium is taken. It is boiled or 
steamed 7 times in cow dung liquid (cow dung mixed in 
water) and 1 times each in tamarind leave juice, cow milk, 
and tender coconut fluid. From this above processed 
semecarpus anacardium, oil is extracted by pit oil method. 
b) 350 gms of neeradi muthu is taken and it is steamed in cow 
dung fluid and dried. The above process is repeated 5 times 
and the seeds are dried well and the kernels are separated 
from the seeds and cleaned. 
c) 350 gms of parangipattai is taken and powdered well. 1.3 lits 
of milk is taken in a vessel and its mouth is covered by a piece 
of cloth and is tied tightly. The paragipattai powder is then 
spreaded on the cloth and is covered by another vessel.it is 
syeamed well. After steaming it is dried under shadow and 
powdered well. 
d) 70 gms of pirappan kilangu, karunjeeragam, seeragam, 
vasambu, vatakarappan pattai, sivanarvembu, sanganverpattai, 
kollankovai, amukkara kilangu, vellarugu, erukkan ver, 
athipattai, kumilaverpattai, sathisaranai kilangu, milagaranai 
kilangu, sengathiri pattai, senthoti pattai, veppan kottai 
paruppu, vetpalaiarisi are taken and dried under the shadow 
and powdered by either grinding or stroking and all the 
powders are mixed well. 
e) 17 ½ gms of thurrusu, paal thutham, kanthegam, rasam are 
taken. First rasam and kanthegam are grinded well upto which 
the mixture gets black color then other materials are added 
and grinded, then the powder is collected. 
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f) 280 gms of ellu and 1400  gms of pan jaggery are taken and 
disolved well in the water and boiled, when the boiling 
process begins it is filtered and the fluid is collected. Then the 
fluid is again collected upto a certain level until it gets it 
consistency. 
all the above powders and the pit oil gbtained from the process a. are  
mixed well and rubbed well in the kalvam and slowly the fluid obtained 
from the process f. is added and grinded for upto 1 and 3/4 hrs. then it is 
collected in a air tight container.  
DOSE: 
           500-700 mg 
EXTERNAL MEDICINE:  
KALAPAIKILANGU VELIPOOCHU 
                          
Ingredients :      
Kalappai kizhangu (rhizome of glorisa superb)   - 5 gms              
Karbogi (seeds of Psoralia corylifolia)    -5 gms 
Karunjeeragam (seeds of Nigella sativa)    -5 gms 
Kattujeeragam (seeds of vernonia anthelmentica)  -5 gms 
 
 Method of preparation: 
   Above raw drugs are grinded and mixed well and made 
into paste form. This paste is applied externally.  
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PROPERTIES OF TRIAL DRUGS: 
INTERNAL MEDICINE: 
NEERADI MUTHU VALLATHY MELUGU 
1) Nruhq;nfhl;il; ;; ;; ;  (Semecarpus anacardium- Anacardiaceae) 
Parts Used                : Fruits and seeds 
Therapeutical Action:     Alterative, Caustic 
nghJf;Fzk;: 
‘Nrq;nfhl;il  nka;j;jpkpiuj;jPuhf; fbtplj;ijg; 
gq;nfhl;L %yj;ijg; gw;Wf;Fk; - Mq;nfl;bf; 
nfhy;YkPth ej;jpndhU Fd;kj;ij Ak;kjid 
                    nty;Yk; mapw;fz;zha; tps;” 
2) ePubKj;J:P ;P ;P ;  
 Botanical Name  : Hydnocarpus inobrians/ Laurifolia 
 Family   : Bixaceae 
     NtWngah;fs;   : ePub, ePnul;b Kj;J 
Vernacular names: 
  Sanskrit  : Garudaphala 
  Hindi  : Chaulmoogra 
  Telugu : Adi-badam 
Classification 
  Class   : Dicotyledons 
  Subclass : Polypetalae 
  Series  : Thalami florae 
  Order  : Paraitales 
  Family : Bixaceae 
  Genera : Hydnocarpus 
  Species : Laurifolia 
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Organoleptic Characters  
  Useful Parts: Oil of seeds 
 Rit  :  ifg;G> ntFl;ly; 
 jd;ik :  ntg;gk; 
 gphpT  :  fhh;g;G 
Therapeutic actions 
  Alterative 
  Stimulant 
  Detergent 
  Parasiticide 
ePubKj;Jnea;:P ; ;P ; ;P ; ;  
 ‘G+RFb thjfzk; nghq;F fpue;jp gil ; ; ;; ; ;; ; ;  
   tPRFl;lk; #iyapit tpl;NlFk; NjrQ;rr;P ; ; ; ; ; ;P ; ; ; ; ; ;P ; ; ; ; ; ; 
    rPubia nahj;jeilj; nja;t klkapNyP ; ; ;P ; ; ;P ; ; ;  
   ePubKj; jpd;nda;ia eP P ; ; ; PP ; ; ; PP ; ; ; P “ 
- mfj;jpah; Fzthflk; ;; ;; ; ; 
,e;nea;ia NkYf;Fg; G+rpdhYk; cs;Sf;Ff; nfhLj;jhYk> 
tspf;$l;lk;, rpuq;F, nrhwp, ngUNeha;, #iy Kjypait ePq;Fk;. 
ChemicalConstituents   
                  Hydnocarpus seeds have long been used in south India as a remedy 
for leprosy, chronic skin affections and ophthalmic as a dressing for wounds 
and ulcers. 
3) . gwq;fpg;gl;il(; ; ;; ; ;; ; ; Similax  chinensis – Liliaceae) 
Parts used:   bark  
Therapeutic actions: Alterative, Antisyphlitic, Aphrodisac, Depurative. 
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nghJFzk;: 
jhfk; gythjQ; jhJel;lk; Gz;gpsit 
Nkfq; fbfpue;jp tPo;%ye; - NjfKld; 
Fl;il gfe;jNkw; nfhs;tkdk; Nghk;gwq;fpg; 
gl;ilapid Ar;rhpj;Jg; ghh;. 
4)gpug;gq;fpoq;F(; ; ;; ; ;; ; ; calamus rotang): 
Parts used: Rhizome 
Therapeutic actions: Expectorant, antivatha 
5) fUQ;rPufk;; P ;; P ;; P ;(Nigella sativa -  Ranunculaceae) 
Parts used: Seeds 
Therapeutic actions: carminative, Diuretic, emmenague,galactogogue, 
anthelmintic, Stomachic, Parasiticide, Emolient. 
6) ew;rPufk;(; P ;; P ;; P ;  Cuminum cyminum- Umbelliferae) 
Parts used: seeds  
Therapeutic actions: Carminative, Stimulant, Stomachic, Astringent. 
7) trk;G;;;  (Acorus Calamus- Araceae) 
Part used  : Rhizome 
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Fzk;;;; 
“ghk;ghjp eQ;rhw; Gjg;Gz; typtplghfq; Fd;kk ; 
#k;gh epuj;jgpj; jk;Kf ehw;wk;td; #iyre;jp 
tPk;ghk;ik fhrk; gpyPfQ; rpypgjk; tPwpUky; 
jhk;ghq; fpUkp apitnaF khrpt rk;gpidNa” 
- gjhHj;j Fztpsf;fk; (g 628) 
8) rptdhh; Ntk;; ;; ;; ;G( Indigofera aspalathoides-fabaceae)  
Parts used: ,iy> G+> jz;L> Ntu; 
Therapeutic actions: stimulant, demulcent. 
9) rq;fd;; ;; ;; ; (Azima tetracantha – Salvadoraceae) 
Part used: Root 
Therapeutic actions: diuretic, Stimulent, astringent, tonic, Antiperiodic.  
10)nfhy;yd; Nfhit; ;; ;; ;  (rhizome of corollocarpus epigaeus): 
NtW ngah;: MfhrfUld; 
Parts used: Rhizome 
Therapeutic actions : Alterative, tonic 
11) mKf;fuh ;;; - (Withania somnifera- Solanaceae) 
Part used : Dried root.  
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nghJFzk;:;;;  
          ‘nfhQ;e; Jth;g;ghq; nfhbafak; #iyaup 
      kpQ;Rfug; ghd;ghz;L ntg;gjl;G-tpQ;rp”.  
      - mfj;jpah; Fzthlfk; ; ; ;; ; ;; ; ;  
13) nts;sWF;;;  ( Enicostemma axillare – Gentianaceae)  
Parts used: whole plant 
Therapeutic Actions: stomachic, tonic, Alterative, laxative, frebrifuge. 
14) vUf;F(;;;  Calotropis gigantean) 
Part Used: NtH. 
Therapeutic Action:  
NtHg;gl;il; ;; ;; ;  
clw;Njw;wp  - Alterative 
Nfhioafw;wp - Expectorant 
nghJf;Fzk;; ;; ;; ; 
 ‘kd;didAq; ifnaLf;f itj;njapw;wp Ndafw;wp 
  Ad;D gpzpg;gzpia Nahl;L;jyhw; - nrhd;Ndd; 
 vUf;nfdNt G+kp apdpNy  tpsq;Fk; 
  mUf;f kUf;fndd yhk' 
 ,J xU fw;g kUe;J. 
      - Njud; ntz;gh 
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15) mj;jp;;; (barks of ficus racemosa): 
 Rit: Jth;g;G; jd;ik  : jl;gk; gphpT  : ,dpg;G;  
 Therapeutic actions: Astringent 
16) Fkpok; Nth;g;gl;il; ; ; ;; ; ; ;; ; ; ; (root bark of gmelina arbora): 
 Rit  : ifg;G; jd;ik  : ntg;gk; gphpT  : fhh;g;G; 
 Therapeutic actions: stimulant, febrifuge. 
17)rj;jprhuid;;; (rhizome of trianthema decandra): 
 Rit  : ifg;G; jd;ik  : ntg;gk;  gphpT  : fhh;g;G; 
 Therapeutic actions: Expectorant, Laxative, Diruetic 
18)kpsfuid(rhizomes of toddalia asaitica): 
 Rit: Jth;g;G; jd;ik  : jl;gk;  gphpT  : fhh;g;G; 
 Therapeutic actions: stimulant, tonic, carminative, Diaphoretic, 
Antiperiodic 
19)Ntg;gq;nfhl;il(; ; ;; ; ;; ; ; Azadirachta indica- Meliaceae)  
         Useful parts   : Seeds 
 Rit  : ifg;G; jd;ik  : ntg;gk;  gphpT  : fhh;g;G; 
Therapeutic action: Stimulant, Anthelmintic, Discutient 
Fzk;  ;;;  
‘fpUkpFl;l khe;jq; nfLtplQ;R uq;fs;; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ; 
 nghUkpa #hpifapd; Gz;fs;; ; ;; ; ;; ; ;-xUkpf;f;;;  
 epk;gj; jpiyapUf;f ePLyfpy; ePq;fhky;; ; ; P ; P ; ;; ; ; P ; P ; ;; ; ; P ; P ; ; 
 fk;gj; jpiyapUf;ff; fhz;; ; ; ; ;; ; ; ; ;; ; ; ; ;” 
- mfj;jpah; Fzthflk;; ; ;; ; ;; ; ; 
tapw;Wg;GO> ngUNeha> khe;jk;, er;RRuk;> mk;ikg;Gz;, 
nrhwp, rpuq;F ,itfis Nghf;Fk;. 
20)ntl;ghiy;;; (seeds of wrightia tinctoria): 
 Rit  : ,dpg;G; jd;ik  : jl;gk;  gphpT  : ,dpg;G; 
Therapeutic actions: tonic  
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21)JUR(copper sulphate): 
 Therapeutic actions: tonic, astringent, emetic, antiseptic, caustic 
 nghJ Fzk;:  
  ‘Gz;zhw;Wq; fhkpaj;jpd; Gz;zhw;Wq; fz;Nzhia 
  tpz;Nzw;W Kj;Njhl TPwlf;FQ;- rz;Zfpd;w 
  the;jpnahL NgjpjUk; tha;Neha; Rue;jzpf;Fq; 
  fhe;ep jUe;JhpR fhz;” 
22)ghy;Jj;jk;(; ; ;; ; ;; ; ; zinc sulphate): 
 Therapeutic actions: tonic, astringent, emetic, anti spasmodic. 
 nghJ Fzk;:  
  “Kw;wpa Fwpg;Gz; KiwtpuzQ; nrd;dpjidg; 
  gw;wpepd;w thjk; glh;fug;ghd;- Rj;jtpopf; 
  fhrq; fzk;gpy;yq; fz;Nzha;Fe; je;njhiyAk; 
  thrkpF Jj;jj;jhy; tho;j;J”  
23) fe;jfk; ; ;; ;; ; ( Rhombic sulphur): 
   Characters:  Rit: frg;G> Jth;g;G 
                                      
TherapeuticAction:Laxative>Cholagogue>Antiseptic,Alterative,Diaphoretic  
 
nghJf;Fzk;;; ; :- 
 ‘ney;ypf;fha;f; fe;jpf;F ePs;gjpndd; Fl;lke;jk;  
 ty;iy ftpir Fd;k thAfz;Nzha; - nghy;yh 
 tplf;fbtd; NkfNeha; tPWRuk; Ngjp 
 jplf;fpuf zPfgk;Nghe; Njh;” 
,J gQ;rG+jq;fspy; NjAtpd; $WilaJ 
 118 
24) urk;(;;; Mercury): 
 Rit:mWRit; tPhpak:; ntg;gk; & rPjk;;;;  gphpT: Jid kUe;Jfspd; 
gphpT   
 Therapeutic actions: Alterative, tonic, Laxative, Antibilous, 
Deobstruent, sialagogue and diuretic. 
nghJFzk;: 
  ‘tpopNeha; fpue;jpFd;kk; nka;r;#iy Gz;Fl; 
  lopfhypy; tpe;Jtpdhy; mj;ij - topaha; 
  GhpA tpjp ahJ GhpapNdh nay;yhk; 
  ,hpAtpjp ahJ kpy;iy” 
25)vs; (;;; sesamum indicam-Pedaliaceae) 
Parts used     :      ,iy>fha;>G+> tpij 
Therapeutic actions:  Demulcent, Laxative, Nutritive, Emoilient  
nghJFzk;: 
‘Gj;jp eadf; Fsph;r;rp G+hpg;G nka;g;GsfQ; 
rj;Jtq; fhe;jp jdpapsik nkj;jTz;lhq; 
fz;Nzha; nrtpNeha; fghy moy; fhrNeha; 
Gz;Nzha;Ngh nkz;nza;ahw; Nghw;W” 
26) gdq;fUg;gl;b(gid); ; ;; ; ;; ; ;  - Borassus flabelliformis- 
Parts used: panjaggery 
Therapeutic Actions: 
  Astrigent, Aphrodisiac, Diuretic, Demulcent, Nutrient, 
Refrigerant Stimulant, Antiphologistic  
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EXTERNAL MEDICINE:  
KALAPAIKILANGU VELIPOOCHU 
1)fyg;igf;fpoq;F:; ; ;; ; ;; ; ;  
Botanical name     : Gloriosa Superba 
Family           : Liliaceae 
NtWngah;fs;    : fhe;jl;fpoq;F, ntz;Njhd;wpf;fpoq;F 
Classfication: 
 Class     : Monocotyledons 
 Series    : Coronariae 
 Family   : Liliaceae 
 Genera   : Gloriosa 
 Species  : Superba 
     Organoleptic Characters 
Useful parts   : Tubers 
Rit       : ifg;G 
jd;ik    : ntg;gk; 
gphpT          : fhh;g;G 
Therapeutic actions  
 Alterative 
 Antiperiodic  (Kiwntg;gfw;wp) 
 Purgative  
Fzk; ;;;  
  ‘ NjtpAuj; ijAkh Njtgy ijANkh 
      uhtpnadf; fl;bAw thf;FNk NehTfis 
    Nad;W nfhz;L khl;Kik apd;kjiy fpy;yplhkQ; 
      Njhd;wpnaDq; fhe;jobj; J}s;”. 
- Njud; ntz;gh  
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,jdhy; Njhiyg;gw;wpaNeha;, Njs;fspd;fbeQ;R nts;is, 
vUtha;%is, tapw;Wtyp, ngUNeha;, tapw;Wg;GO ,itfs; ePq;Fk; ,J 
gpj;jj;ij mjpfhpf;fr; nra;Ak;, ,ij mjpf mstpy; nfhs;s eQ;rhFk;. 
Chemical Constituents 
 Alkaloids  
         Cochicine,  
         Gloriosine 
Externally it is used as a local applicant for psoriatic skin diseases. 
 The tuber extract shows antibiotic activity against staphylococcus 
aureus. 
2) fhh;Nghfuprp;;;  (Psoralea corylifolia -  Fabaceae.): 
Part used : The dried fruit  
Therapeutic actions: Laxative, Stimulant.  
3) fUQ;rPufk;; P ;; P ;; P ;(Nigella sativa -  Ranunculaceae): 
Parts used: Seeds 
Therapeutic actions: carminative, Diuretic, emmenague,galactogogue, 
anthelmintic, Stomachic, Parasiticide, Emolient. 
4)fhl;L rPufk;; P ;; P ;; P ; (seeds of vernonia anthelmentica): 
Parts used: Seeds 
Therapeutic actions: anthelmintic, stomachic, tonic, Diuretic, 
Antiperiodic, Alterative  
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ANNEXURE - II 
BIO-CHEMICAL ANALYSIS OF NEERADIMUTHU VALLATHI 
MELUGU 
Preparation of the Extract 
5 gram of the drug was weighed accurately and placed in a 250 ml 
clean beaker, and then 50ml of distilled water was added and dissolved 
well. Then it was boiled well for about 10 minutes. It was cooled and 
filtered in a 100ml volumetric flask and then it was diluted to 100ml with 
distilled water. This fluid was taken for analysis.  
S. 
NO 
EXPERIMENT 
OBSERVATION INFERENCE 
1. TEST FOR CALCIUM 
2ml of the above prepared 
extract was taken in a clean 
test tube.  To this added     2 
ml of 4% Ammonium oxalate 
solution was added. 
A  White 
precipitate is 
formed. 
Indicates the 
presence of 
calcium. 
2. TEST FOR SULPHATE: 
2ml of the extract was added 
to 5% barium chloride 
solution. 
white precipitate is 
formed. 
Indicates the 
presence of 
sulphate 
3. TEST FOR CHLORIDE 
The extract was treated with 
silver nitrate solution. 
 No white 
precipitate is 
formed. 
Absence of 
chloride. 
4. TEST FOR CARBONATE 
The extract was treated with 
concentrated HCL. 
No brisk 
effervescence is 
formed. 
Absence 
Of 
Carbonate. 
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5. TEST FOR STARCH 
The extract was added with 
weak iodine solution. 
Blue colour is 
formed. 
Indicates the 
presence of 
starch. 
6. TEST FOR IRON FERRIC 
The extract was treated with 
concentrated Glacial acetic acid 
and potassium ferro cyanide.  
No blue colour is 
formed. 
Absence of 
ferric iron. 
7. TEST FOR IRON FERROUS: 
The extract was treated with 
concentrated Nitric acid and 
ammonium thio cyanate. 
Blood red colour 
is formed. 
Indicates the 
presence of 
Ferrous Iron. 
8. TEST FOR PHOSPHATE 
The extract was treated with 
ammonium Molybdate and 
concentrated Nitric acid. 
No yellow 
precipitate is 
formed. 
Absence of 
phosphate. 
9. TEST FOR ALBUMIN  
The extract was treated with 
Esbach’s reagent. 
 No yellow 
precipitate is 
formed. 
Absence of  
Albumin. 
10. TEST FOR TANNIC ACID 
The extract was treated with 
ferric chloride. 
No blue black 
precipitate is 
formed. 
Absence of 
Tannic acid. 
11. TEST FOR UNSATURATION 
Potassium permanganate 
solution was added 
to the extract. 
It gets decolorized. 
Indicates the 
presence of 
unsaturated 
compound. 
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12. TEST FOR THE 
REDUCING SUGAR 
5ml of Benedict’s qualitative 
solution was taken in a test 
tube and allowed to boil for 2 
mts and added 8-10 drops of 
the extract and again boil it for 
2 mts. 
Colour change 
occurs 
 Indicates the 
presence of 
Reducing 
Sugar. 
13. TEST FOR AMINO ACID: 
One or two drops of the extract 
was placed on a filter paper 
and dried it well. After drying, 
1% Ninhydrin was sprayed 
over the same and dried it 
well. 
 No Violet colour  
is formed 
Absence of 
Amino acid. 
 
14 TEST FOR ZINC 
The  extract  is treated with 
potassium ferrocyanide 
 
No white 
precipitate is 
formed 
Absence of zinc 
 
 
INFERENCE 
 Indicates the presence of Calcium. 
 Indicates the presence of Sulphate. 
 Indicates the presence of Starch. 
 Indicates the presence of ferrous iron. 
 Indicates the presence of unsaturated compounds. 
 Indicates the presence of reducing sugar. 
 
 128 
 
ANNEXURE - III 
PHARMACOLOGICAL ANALYSIS 
INTERNAL MEDICINE 
ACUTE ANTI-INFLAMMATORY STUDY ON NEERADIMUTHU VALLATHY 
MELUGU 
Aim: 
To study the acute anti-inflammatory effect of NEERADIMUTHU 
VALLATHY MELUGU by Hind- paw method in albino rats. 
Procedure: 
 Nine healthy albino rats weighing 100-150 gm were taken and divided 
into three groups, each consisting of three rats. 
First group was kept as control by giving distilled water orally 
2ml/100gm body weight. The second group was given ibuprofen at a dose of 
20mg /100gm body weight. The third group received the test drug at a dose of 
100mg /100g body weight. 
Before administration of drugs, the hind-paw volumes of all rats were 
measured. This was done by dipping the hind-paw upto the tibio-tarsal junction 
into a mercury plethysmograph. While dipping the hind-paw, by pulling the 
syringe piston, the level of mercury in the centre small tube was made to 
coincide with red marking and reading was noted from the plethysmograph. 
Soon after measurement, the drugs were administered orally. One hour 
later, a sub-cutaneous injection of 0.1ml of 1% (W/V) carrageenan in water 
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was made into plantar surface of both hind-paws of each rat. Three hours after 
carrageenan injection, the hind paw volume was measured once again. The 
difference between the initial and final volume was calculated and compared. 
This method is more suitable for studying the anti-inflammatory activity in 
acute inflammation. The values are tabulated. 
Effect of NEERADIMUTHU VALLATHY MELUGU 
Group 
Dose / 
100gm 
of 
body 
weight 
Initial 
reading 
average 
Final 
reading 
average 
Mean 
difference 
% of 
inflammation 
% of 
inhibition 
Control 
(water) 
2 ml 0.55 0.4 0.85 100 - 
Standard 
(ibuprofen) 
20mg 0.55 0.75 0.20 22.2 77.8 
Test drug 
(Neeradimuthu 
vallathy 
melugu) 
100mg 0.7 0.95 0.25 29.4 70.6 
 
Result: 
 From the above experiment it is concluded that the test drug has good 
Significant Anti-inflammatory action in acute inflammatory condition. 
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CHRONIC ANTI-INFLAMMATORY STUDY BY  
COTTON-PELLETS GRANULOMA METHOD 
Drug 
        NEERADIMUTHU VALLATHY MELUGU  
Aim 
To study the chronic anti-inflammatory activity of the drug in albino rats 
by cotton pellets implantation (granuloma) method. 
Procedure: 
 Cotton pellets each weighing 10mg was prepared and sterilized in an 
autoclave for about one hour under 15 lbs atmosphere pressure.  Nine Albino 
rats weighing between 100-200gm were selected and were divided into 3 
groups.  Each rat was anaesthetized with ether and cotton pellets were 
implanted subcutaneously in the groin, two in each side. 
First group was kept as control group giving distilled water of 
1ml/100gm of body weight. To the second group the standard drug Ibuprofen 
in a dose of 20mg/100gm body weight was given.  The third group of animals 
was given test drug Neeradimuthu vallathy melugu in a dose of 
100mg/100gm of body weight 
On the eighth day the rats were sacrificed and the pellets were removed 
and weighed.  Then they were put in an incubator at 60ºC-80ºC and then 
weighed. 
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The concordant weight was noted for all groups and compared. 
The effect of Neeradimuthu vallathy melugu in chronic anti 
inflammatory study. 
S.No Group 
Dose/100 
gm body 
weight 
Pellet 
Weight 
Pallet 
Weight of 
the 
Granuloma 
of drugs 
Percentage of 
Inflammation 
Percentage 
of 
Inhibition 
1 
Control 
(water) 
2  ml 10mg 250mg 100 - 
2 
Standard 
(lbuprofen) 
20mg 10mg 55mg 22 78 
3 
Test drug 
(Neeradimuthu 
vallathy 
melugu) 
100mg 10mg 120mg 48 52 
 
INTERFERENCE 
 The drug shows moderate chronic – anti inflammatory action. 
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ANTI- HISTAMINE EFFECT OF NEERADIMUTHU VALLATHY MELUGU 
ON ISOLATED ILEUM OF GUINEA PIG 
Preparation of the Drug: 
 0.1ml NEERADIMUTHU VALLATHY MELUGU was dissolved in 100ml of 
water and decoction was made out of it. This was used for the studies. 
Method: 
 A guinea pig weighing about 450gms was starved for 48hrs and only 
water was allowed. It was killed by stunning with a sharp blow on the head and 
cutting its throat to bleed it, to death. The abdomen was quickly opened and the 
viscera inspected and loops of intestine identified using the batch as a land 
mark. Then the ileum was removed and placed in a shallow dish containing 
warm ‘Tyrode solution’ mixed with Atropine with the help of 25ml pipette, the 
lumen was gently rinsed out with saline. It was cut in to segments of required 
length, generally 4cm, in a full relaxed state and the sutures were made with 
needle and tied at either ends, and the segment is suspended in an isolated 
organ bath. It was aerated by oxygen tube and immersed in Tyrode solution at 
37
0
C. Drugs were given to study the inhibitory effect of histamine induced 
contractions. 
INFERENCE 
 Neeradimuthu vallathy melugu has significant anti histamine action 
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ANTI HISTAMINE ACTION OF NEERADIMUTHUVALLATHY 
MELUGU 
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GOVT SIDDHA MEDICAL COLLEGE- PALAYAMKOTTAI 
PHARMACOLOGICAL ANALYSIS  
ANALGESIC STUDY OF NEERADIMUTHU VALLATHY MELUGU 
 
Aim: 
 To study the analgesic effect on albino rats by tail flick method. 
Preparation of the test Drug: 
            1 gram of Neeradi muthu vallathy melugu  was suspended in 10ml of 
Hot 
Water as suspending agent. This 1 ml contained 100mg of the test drug. 
 
Procedure: 
                 Nine Male Healthy albino rats (weighing 80-100gms) were used for 
this study. The animals were allowed, free access to food and water until they 
brought for the experiment. The animals which showed the positive response to 
the stimulus (within a given time) were selected for the study. After the 
selection of animals which were responding to stimulus within 2 seconds, they 
were divided into three groups, each group consisting of three rats. 
                 The hot water was maintained at 55°C. The tip of the tail was 
immersed into the water bath and the time was noted when the rat flicked the 
tail. First group was given 1ml of water and kept as control. Second group was 
administered with paracetamol at a dose of 20mg/100gm of body weight. Third 
group as given the dose of 100mg/100gm body weight of the animal .After the 
drug administration, the reaction time of each rat after half an hour and one 
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hour were noted in each group (when a rat fails to flick the tail, it should not be 
continued beyond 8 seconds to avoid injury) and the average was calculated. 
The results of control group, standard group and drug treated group were 
tabulated and compared. 
STUDY OF ANALGESIC EFFECT USING THE DRUG 
NEERADIMUTHU  VALLATHY MELUGU 
 
After drug administration 
 
Name of the 
Groups 
 
Dose/ 
100 
gram 
body 
weight 
 
 
Initial 
reading 
 
½ hr 
Average 
 
1 hr 
Average 
 
1 1/2hr 
Average 
 
 
Mean 
difference 
 
Control 
(Water) 
 
 
2 ml 
 
2.0 sec 
 
2.0 sec 
 
2.0 sec 
 
2.0 sec 
 
0.0 sec 
 
Standard 
(Paracetamol) 
 
 
20 mg 
 
2.0 sec 
 
2.5 sec 
 
4.5 sec 
 
6.5 sec 
 
6.5 sec 
 
Test drug 
(NMVM) 
 
100 
mg 
 
2.0 sec 
 
2.5 sec 
 
4.5 sec 
 
6.0 sec 
 
6.0 sec 
 
NMVM- Neeradimuthu Vallathy melugu 
Inference: 
                The trial drug had significant analgesic action. 
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EXTERNAL MEDICINE 
ACUTE ANTI- INFLAMMATORY STUDY ON 
KALAPPAI KILANGU VELIPUCHU (EXTERNAL) 
Aim 
To study the acute anti-inflammatory effect of kalappai kilangu 
velipuchu (External) by Hind-paw method in albino rats. 
Procedure: 
Nine albino rats were selected weighing between 100 - 150 grams and 
divided into three groups each containing three rats. To the first group distilled 
water was given and kept as control. Before the application of the drug, the 
hind - paw volume of all rats were measured. This was done by dipping the 
hind paw upto the tibio - dorsal junction in mercury plethysmography. 
Subcutaneous injection of 0.1% of carrageenan (W/v) in water was made into 
plantar surface of both the hind - paw of each rat. To the second group the 
standard drug Ibuprofen in a dose of 20mg/100gm body weight was given. To 
the test group Kalappai kilangu velipuchu was topically applied frequently 
over the inflammed surface in a thin layer. To the control group, no drug was 
applied over the inflammed surface. One and half hours after injection the hind 
paw volume was measured once again. The difference between the initial and 
final volumes would show the amount of inflammation. Taking the volume in 
 137 
the control group as 100% of inflammation, the anti - inflammatory effect of 
the group is calculated. 
 
Group 
Dose / 
100gm 
of 
body 
weight 
Initial 
reading 
average 
Final 
reading 
average 
Mean 
difference 
% of 
inflam
mation 
% of 
inhibition 
Control 
(water) 
2 ml 0.55 1.45 0.85 100 - 
Standard 
(ibuprofen) 
20mg 0.55 0.75 0.20 22.2 77.8 
TD 
(Kalappai 
kilangu 
velipuchu) 
- 0.87 1.15 0.28 32.9 67.1 
 
TD- Test Drug 
INFERENCE 
 The drug has SIGNIFICANT acute anti-inflammatory action. 
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ANNEXURE – IV 
ASSESSMENT FORMS 
FORM I    -          SCREENING FORM 
FORM II  -          CONSENT FORM 
FORM III  -        CASE SHEET PROFORMA 
FORM IV  -         LABORATORY INVESTIGATIONS 
FORM V  -          CLINICAL ASSESSMENT 
FORM VI  -         PATIENT WITHDRAWAL FORM 
FORM VII  -        DRUG COMPLIANCE FORM 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI.  
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF ‘NEERADIMUTHU  VALLATHY 
MELUGU’ AND ‘KALAPPAI KILANGU VELIPUCHU FOR THE 
TREATMENT OF ‘KALANJAGA PADAI’ (PSORIASIS) 
FORM I –SCREENING FORM 
1. OP/ IP No:                                          2. BED No:                        3. Sl. No:  
 4.   NAME:                                             5. AGE:                              6. GENDER:  
 7.   OCCUPATION:                               8. SOCIAL STATUS: 
9.  DATE OF ADMISSION:                 10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
a) INCLUSION CRITERIA: 
1. Age: between 14 years and 60 years 
2. Sex:  Both Male and Female 
3. Patients having the symptoms of Kalanjaga padai 
4. Psoriatic arthritis 
5. Auspitz sign positive 
6. Koebner’s phenomenon positive 
7. Candle grease sign positive 
8. Willing to participate in the study 
9. Willing to give specimens for the investigations whenever required 
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b) EXCLUSION CRITERIA: 
1. Diabetes Mellitus 
2. Hypertension and Cardiac diseases 
3. Narcotic addicts 
4. Pregnancy and Lactation 
5. HIV 
6. Leprosy 
7. Peptic ulcer 
8. Patients with any other serious illness 
c) WITHDRAWAL CRITERIA: 
1. Development of any adverse reaction (ADR).  
2. Occurrence of any other systemic illness. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF ‘NEERADIMUTHU  VALLATHY MELUGU’ 
AND ‘KALAPPAI KILANGU VELIPUCHU FOR THE TREATMENT OF 
‘KALANJAGA PADAI’ (PSORIASIS) 
Form: II CONSENT FORM 
CERTIFICATE BY INVESTIGATOR 
I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
                                                                                                         
Signature………………….                                                                                                                                                                         
Date………                     
Name…………………… 
  
CONSENT BY PATIENT 
              I have been informed to my satisfaction, by the attending physician, 
the purpose of the clinical trial, and the nature of drug treatment and follow-up 
including the laboratory investigations to be performed to monitor and 
safeguard my body functions.  
I am aware of my right to opt out of the trial at any time during the 
course of the trial without having to give the reasons for doing so. 
I, exercising my free power of choice, hereby give my consent to be 
included as a subject in the clinical trial of ‘neeradimuthu  vallathy melugu’ 
(internal drug)’ and ‘kalappai kilangu velipuchu’ (External drug)’ for the 
treatment of ‘KALANJAGA PADAI’ (PSORIASIS) 
                                                                                                                                 
Signature…………………                             
Name……………………..                                                    
Date………………….. 
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murpdH rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;J; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; tkid > 
ghisaq;Nfhl;il; ;; ;; ;  
gl;lNkw;gbg;G rpwg;GkUj;Jtj;Jiw 
‘ePubKj;J ty;yhjp nkOFP ; ;P ; ;P ; ; ” kw;Wk; ; ;; ;; ; ‘fyg;igf;fpoq;F ntspg;G+r;R; ; ; ; ;; ; ; ; ;; ; ; ; ; ”  
,tw;wpd; gupfupg;Gj;jpwidf; fz;lwpAk; kUj;Jt Ma;T; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;  
Xg;Gjy; gbtk;; ; ;; ; ;; ; ; 
Ma;thsuhy; rhd;wspf;fg;gl;lJ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GupAk; 
tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
Njjp:                                 ifnahg;gk;: 
,lk;:                                   ngau;: 
Nehahspapd; xg;Gjy;; ; ;; ; ;; ; ; 
             vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; 
kUe;jpd; jd;ik kw;Wk; kUj;Jt topKiwiag; gw;wpAk; njhlu;e;J vdJ 
cly; ,af;fj;ij fz;fhzp;f;fTk>; mjidg; ghJfhf;fTk; gad;gLk; 
kUj;Jt Ma;Tf;$l gupNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; 
Ma;T kUj;Jtuhy; tpsf;fpf; $wg;gl;lJ. 
ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; 
vg;nghOJ Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; 
nfhs;Sk; cupikia njupe;jpUf;fpd;Nwd;. 
ehd; vd;Dila Rje;jpukhfj; Nju;T nra;Ak; cupikiaf; nfhz;L 
fhshQ;rfg;gil vd;Dk;  Neha;f;fhd ‘ePubKj;J ty;yhjp nkOFP ; ;P ; ;P ; ; ” 
kw;Wk; ; ;; ;; ; ‘fyg;igf;fpoq;F ntspg;G+r;R; ; ; ; ;; ; ; ; ;; ; ; ; ; ”  Mfpatw;wpd;  gupfupg;Gj; jpwidf; 
fz;lwpAk; kUj;Jt Ma;tpw;F vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;. 
Njjp:                                     ifnahg;gk;: 
,lk;:                                        ngau;: 
Njjp:                             rhl;rpf;fhuh; 
ifnahg;gk;: 
,lk;:                                        ngau; 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF NEERADIMUTHU  VALLATHY 
MELUGU AND KALAPPAI KILANGU VELIPUCHU FOR THE 
TREATMENT OF ‘KALANJAGA PADAI’ (PSORIASIS) 
FORM III - CASE  PROFORMA 
1. OP / IP No                                          2. Sl.No.     
3. Name                 4. Age ________           5. Gender ______ 
6. Marital status  1) Married   2) Unmarried 
7. Occupation 
8. Postal address 
 
 
 
9.  Complaints & Duration 
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10. History of present illness 
 
 
 
 
 
11.  Past history 
 
 
12.  Family history 
 
 
13.  Social Status 
 1)  Low Income  2) Middle Class  3) Higher 
Income 
HABITS                             Yes                          No       
14.    Smoker 
15.    Alcoholic 
16.   Betalnut Chewer 
17.   Non – Vegetarian 
GENERAL EXAMINATION  
18.  Body Weight (kg) 
19.  Body Temperature (°F)         .      
  
  
  
 
 
 
 
 145 
20. Blood Pressure (mmHg)    
21.   Pulse rate / min 
22.  Heart rate / min   
23.  Respiratory rate / min 
              Yes                         No  
24.  Pallor 
25.  Jaundice 
26.  Clubbing 
27.  Cyanosi 
28.  Pedal odema 
29.  Lymphadenopathy 
30.  Engorged veins 
 
CLINICAL EXAMINATION OF SKIN 
     Right      Left  
31.  Site   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . .  
 . . . . . . . . . . . . . . . . . . . . . . .       . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . 
31. Colour   
    1. Normal       2. Reddish        3. Black               4. Greyish 
33.  Shape      
    1.  Irregular            2. Coin shape                     3. Dispersed  
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34. Scaling 
       1. Mild                          2. Moderate                             3. Severe 
35. Itching  
1.  No     2.Mild                   3.Moderate                  4.Severe 
36.  Erythema 
     1. Present    2.Absent 
37   Bleeding 
      1. Present              2. Absent 
38.  Crusting 
      1. Present       2. Absent 
39.  Lichenification 
      1. Present               2. Absent 
40.  Oozing         
      1. No              2.Mild          3.Moderate              4. Severe 
41.  Auspitz sign 
      1. Present         2. Absent 
42.  Koebner’s phenomenon 
      1. Present       2. Absent 
43.  Candle grease sign 
      1. Present               2. Absent 
YES                     NO 
44. Ulceration 
45.  Macule   
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46..  Papule 
47.  Pustule  
48.  Blister 
49.  Vésicule    
50.  Pigmentation  
            1. Normal      2. Hypo              3.Hyper 
EXAMINATION OF NAILS 
51.  Pitting  
     1. Present    2.Absent 
52   Thickening 
      1. Present                 2. Absent 
53.  Collection of Hyperkeratotic debris 
      1. Present                2. Absent 
54.  Separation of distal portion of nail 
      1. Present                2. Absent 
EXAMINATION OF JOINTS 
YES                     NO 
55.  Joint Involvement              If yes:…………………….. 
  EXAMINATION OF VITAL ORGANS 
                                 Normal               Abnormal  
56. CVS              _____________________ 
57.  RS        _____________________ 
58.  Abdomen                 ____________________ 
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SIDDHA ASPECTS 
59.  NILAM 
       1. Kurinji          2. Mullai        3. Marutham      4. Neithal            
      5. Paalai 
60.  KALA IYALBU 
          1. Kaarkaalam        2.  Koothirkaalam       3. Munpanikaalam
      
          4. Pinpanikaalam        5. Ilavenirkaalam    6. Mudhuvenirkaalam 
61.  UDAL IYALBU 
1. Vatham                   2. Pitham      3. Kabam  
  4. Vatha Pitham        5. Vatha Kabam            6. Pitha Kabam   
7. Pitha Vatham      8. Kaba Vatham       9. Kaba Pitham 
62.  GUNA IYALBU 
 1. Sathuvam  2.Rasatham  3.Thamasam 
IYMPORIGAL 
      Normal             Affected    
63. Mei  
64 Vaai   
65. Kan  
66 Mookku   
67. Sevi 
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KANMENDHIRIUM / KANMAVIDAYAM 
   Normal     Affected     
68. Kai        
69. Kaal 
70. Vaai  
71. Eruvaai  
72. Karuvaai  
UYIR THATHUKKAL 
VATHAM         Normal     Affected  
73. Pranan     
74. Abanan    
75. Uthanan           
76. Viyanan       
77. Samanan                              
78. Nagan    
79. Koorman   
80. Kirukaran         
81. Devathathan     
82. Dhananjeyan   
PITHAM  Normal     Affected   
83. Anar pittham         
84. Ranjagam   
85. Sathagam        
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86. Alosagam                
87. Prasagam 
KABAM    Normal     Affected   
 88. Avalambagam 
89. Kilethagam     
90. Pothagam          
91.  Tharpagam       
92. Santhigam 
UDAL THATHUKKAL  
Normal    Affected  
93. Saaram            
94. Senneer               
95. Oon            
96. Kozhuppu            
97. Enbu             
98. Moolai           
99. Sukkilam / 
      Suronitham 
ENVAGAI THERVUGAL 
100.   Naadi            
   Normal        Affected  
101.   Sparisam          
102.  Naa        
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103.  Niram               
104.  Mozhi 
105.  Vizhi                     
MALAM                    Normal     Affected  
106.    Niram     
         Yes                No  
107.    Erugal         
108.    Elagal 
MOOTHIRAM 
Neerkkuri       Normal            Affected  
109.  Niram   
110.  Manam         
111.  Edai        
112.  Nurai   
113.  Enjal      
     114.  Neikkuri 1. Vatha Neer       2. Pitha Neer      3. Kaba Neer 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF ‘NEERADIMUTHU  VALLATHY 
MELUGU’ AND ‘KALAPPAI KILANGU VELIPUCHU’ FOR THE 
TREATMENT OF ‘KALANJAGA PADAI’ (PSORIASIS) 
Form IV - LABORATORY INVESTIGATIONS 
1. OP/ IP No:                                                 2. BED No:          3. Sl. No:  
 4.   NAME:                                                      5. AGE:               6. GENDER:  
 7.   OCCUPATION:                                        8. SOCIAL STATUS 
9.  DATE OF ENROLLMENT:                      10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
Date: 
I. BLOOD: 
1. TC :    (Cells/Cumm)          
2. DC (%):   N                L                        M             E                      
3. ESR (mm) :    ½ hr                           1 hr 
4. Hb:                         
5. Blood Sugar:   a) Fasting                       b) Post prandial                        
6. Kidney function tests: 
              Blood urea:   Serum creatinine:  
 
Lecturer                         HOD 
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7.Lipid profile: 
              HDL:    LDL:              VLDL:  
              Total Cholesterol :                         TGL: 
7. Liver Function tests: 
              SGOT:   SGPT:  Alk. Phosphatase: 
               Albumin:            Globulin:  Total Protein: 
               Serum Bilirubin:             Total               Direct 
                       Indirect : 
    II. URINE: 
1. Albumin :                                                    
2. Sugar :                                                           
3. Epithelial cells   :                 
4. Pus cells             :                 
5. Red blood cells  :                 
6. Casts/Crystals    : 
III. MOTION:    
1. Ova    : 
2. Cyst    : 
3. Occult blood   : 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF ‘NEERADIMUTHU  VALLATHY 
MELUGU’ AND ‘KALAPPAI KILANGU VELIPUCHU’ FOR THE 
TREATMENT OF ‘KALANJAGA PADAI’ (PSORIASIS) 
FORM - V ASSESSMENT PROFORMA 
1. IP / OP No   2. Sl. No 
4.  Name. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
5. Date of admission  
6. Date of discharge 
CLINICAL ASSESSMENT: 
Sl 
No: 
Signs and Symptoms 15
th
 day 30
th
 day 48
th
 day 
1 Scaling    
2 Itching    
3 Thickening    
4 Erythema    
5 Pigmentation    
6 Vesicle    
7 Pustules    
8 Oozing    
9 Crusting    
10 Lichenification    
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF NEERADIMUTHU  VALLATHY 
MELUGU AND KALAPPAI KILANGU VELIPUCHU FOR THE 
TREATMENT OF ‘KALANJAGA PADAI’ (PSORIASIS) 
FORM - VI PATIENT WITHDRAWAL FORM 
1.  OP / IP No                             2. S.No.                    3.Date: __________ 
4.  Name                 5. Age  __________      6. Gender 
________ 
7.  Postal address: 
 
Complaints and Duration: 
 
Irregular Treatment: 
 
Adverse Reactions: 
 
Other causes: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI. 
POST GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF ‘NEERADIMUTHU  VALLATHY 
MELUGU’ AND ‘KALAPPAI KILANGU VELIPUCHU’ FOR THE 
TREATMENT OF ‘KALANJAGA PADAI’ (PSORIASIS) 
FORM VII - DRUG COMPLIANCE FORM 
Name of the Drug: NEERADI MUTHU VALLATHY MELUGU 
Drugs issued: ……………(mgs/Grams) 
Drugs returned:  ……………(mgs/Grams) 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                            Signature of the HOD 
DRUG TAKEN TIME 
S.NO DATE 
MORNING/TIME AFTERNOON/TIME NIGHT/TIME 
Day 1     
Day 2     
Day 3     
Day 4     
..     
..     
Up to day 
48 
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